<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Cancer on VitaminDWiki</title><link>/categories/cancer.html</link><description>Recent content in Cancer on VitaminDWiki</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Wed, 11 Jan 2017 00:00:00 +0000</lastBuildDate><atom:link href="/categories/cancer/index.xml" rel="self" type="application/rss+xml"/><item><title>Ethical challenge – giving vitamin D to only half of Cancer (etc) patients</title><link>/posts/ethical-challenge-giving-vitamin-d-to-only-half-of-cancer-etc-patients.html</link><pubDate>Wed, 11 Jan 2017 00:00:00 +0000</pubDate><guid>/posts/ethical-challenge-giving-vitamin-d-to-only-half-of-cancer-etc-patients.html</guid><description/></item><item><title>Vitamin D, Vitamin D Receptor and Cancer</title><link>/posts/vitamin-d-vitamin-d-receptor-and-cancer.html</link><pubDate>Sun, 04 Dec 2016 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-vitamin-d-receptor-and-cancer.html</guid><description/></item><item><title>Hypothesis: Vitamin D treating of breast and other cancers may be via CCN genes</title><link>/posts/hypothesis-vitamin-d-treating-of-breast-and-other-cancers-may-be-via-ccn-genes.html</link><pubDate>Sat, 15 Oct 2016 00:00:00 +0000</pubDate><guid>/posts/hypothesis-vitamin-d-treating-of-breast-and-other-cancers-may-be-via-ccn-genes.html</guid><description>&lt;h4 id="regulation-of-the-ccn-genes-by-vitamin-d-a-possible-adjuvant-therapy-in-the-treatment-of-cancer-and-fibrosis">Regulation of the CCN genes by vitamin D: A possible adjuvant therapy in the treatment of cancer and fibrosis&lt;/h4>
&lt;p>Cellular Signalling; Vol 28, Issue 10, October 2016, pg 1604–1613; &lt;a href="http://dx.doi.org/10.1016/j.cellsig.2016.07.009">http://dx.doi.org/10.1016/j.cellsig.2016.07.009&lt;/a>&lt;/p>
&lt;p>Richard T. Piszczatowskia, Nathan H. Lentsb&lt;/p>
&lt;p>The CCN family is composed of six cysteine-rich, modular, and conserved proteins whose functions span a variety of tissues and include cell proliferation, adhesion, angiogenesis, and wound healing. Roles for the CCN proteins throughout the entire body including the skin, kidney, brain, blood vessels, hematopoietic compartment and others, are continuously being elucidated. Likewise, an understanding of the regulation of this important gene family is constantly becoming clearer, through identification of transcription factors that directly activate, repress, or respond to upstream cell signaling pathways, as well as other forms of gene expression control. Vitamin D (1,25-dihydroxyvitamin D3 or calcitriol), a vitamin essential for numerous biological processes, acts as a potent gene expression modulator. The regulation of the CCN gene family members by calcitriol has been described in many contexts. Here, we provide a concise and thorough overview of what is known about calcitriol and its regulation of the CCN genes, and argue that its regulation is of physiological importance in a wide breadth of tissues in which CCN genes function. In addition, we highlight the effects of vitamin D on CCN gene expression in the setting of two common pathologic conditions, fibrosis and cancer, and propose that the therapeutic effects of vitamin D3 described in these disease states may in part be attributable to CCN gene modulation. As vitamin D is perfectly safe in a wide range of doses and already showing promise as an adjuvant therapeutic agent, a deeper understanding of its control of CCN gene expression may have profound implications in clinical management of disease.&lt;/p></description></item><item><title>Cancer risk in older women reduced 32 percent by 2,000 IU of Vitamin D plus Calcium – 4 year RCT</title><link>/posts/cancer-risk-in-older-women-reduced-32-percent-by-2000-iu-of-vitamin-d-plus-calcium-4-year-rct.html</link><pubDate>Wed, 12 Oct 2016 00:00:00 +0000</pubDate><guid>/posts/cancer-risk-in-older-women-reduced-32-percent-by-2000-iu-of-vitamin-d-plus-calcium-4-year-rct.html</guid><description>&lt;h4 id="vitamin-d3-and-calcium-supplementation-significantly-decreases-cancer-risk-in-older-women">Vitamin D3 and calcium supplementation significantly decreases cancer risk in older women&lt;/h4>
&lt;p>American Public Health Association 2016 meeting Oct 31, 2016&lt;/p>
&lt;p>Joan Lappe, Creighton University; Dianne Travers-Gustafson, Creighton University; Cedric Garland, University of California at San Diego; Robert Heaney, Creighton University; Robert Recker, Creighton University; Patrice Watson, Creighton University&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:750px">
&lt;p>This RCT did not have an arm for Vitamin D without Calcium&lt;/p>
&lt;p>There is a lot of controversy about Calcium - does it help or harm health?&lt;/p></description></item><item><title>Risk of Cancer increased if poor Vitamin D Receptor – meta-analysis of 73 studies</title><link>/posts/risk-of-cancer-increased-if-poor-vitamin-d-receptor-meta-analysis-of-73-studies.html</link><pubDate>Fri, 23 Sep 2016 00:00:00 +0000</pubDate><guid>/posts/risk-of-cancer-increased-if-poor-vitamin-d-receptor-meta-analysis-of-73-studies.html</guid><description/></item><item><title>Obesity linked to 13 cancers, the linkage is probably vitamin D</title><link>/posts/obesity-linked-to-13-cancers-the-linkage-is-probably-vitamin-d.html</link><pubDate>Fri, 26 Aug 2016 00:00:00 +0000</pubDate><guid>/posts/obesity-linked-to-13-cancers-the-linkage-is-probably-vitamin-d.html</guid><description>&lt;p>&lt;strong>Fact:&lt;/strong> Obesity lowers vitamin D&lt;/p>
&lt;p>&lt;strong>Fact:&lt;/strong> Low vitamin D increases the risk of many diseases – such as cancers&lt;/p>
&lt;p>&lt;strong>Examples of web reporting&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="http://khn.org/news/another-reason-to-diet-experts-find-additional-evidence-of-obesity-cancer-link/">Another Reason To Diet: Experts Find Additional Evidence Of Obesity-Cancer Link&lt;/a> Kaiser&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="http://well.blogs.nytimes.com/2016/08/24/obesity-linked-to-at-least-13-types-of-cancer/?_r=0">Obesity Is Linked to at Least 13 Types of Cancer&lt;/a> New York Times&lt;/p>
&lt;/li>
&lt;/ul>
&lt;table>
 &lt;thead>
 &lt;tr>
 &lt;th>&lt;/th>
 &lt;th>&lt;/th>
 &lt;/tr>
 &lt;/thead>
 &lt;tbody>
 &lt;tr>
 &lt;td>Type of Cancer&lt;/td>
 &lt;td>Some studies in VitaminDWiki&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>adenocarcinoma of the esophagus&lt;/td>
 &lt;td>&lt;a href="/posts/cancer-of-glands-adenocarcinoma-associated-with-2x-lower-vitamin-d-levels">Cancer of glands (Adenocarcinoma) associated with 2X lower vitamin D levels – Aug 2013&lt;/a>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>colorectal cancer&lt;/td>
 &lt;td>&lt;a href="/posts/overview-cancer-colon-and-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Overview Cancer-Colon and vitamin D">Overview Cancer-Colon and vitamin D&lt;/a>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>breast cancer in postmenopausal women&lt;/td>
 &lt;td>&lt;a href="/posts/overview-breast-cancer-and-vitamin-d">Overview Breast Cancer and Vitamin D&lt;/a>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>uterine cancer&lt;/td>
 &lt;td>&lt;a href="/posts/endometrial-cancer-and-vitamin-d-many-studies">Endometrial cancer and Vitamin D – many studies&lt;/a>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>kidney cancers&lt;/td>
 &lt;td>&lt;a href="/posts/5x-less-risk-of-kidney-cancer-if-good-ratio-of-vitamin-d-binding-protein-to-circulating-vitamin-d">5X less risk of Kidney cancer if good ratio of Vitamin D binding protein to circulating vitamin D – Nov 2013&lt;/a>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>&lt;strong>The study added the following cancers&lt;/strong>&lt;/td>
 &lt;td>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>gastric cardia, a cancer of the part of the &lt;br>stomach closest to the esophagus;&lt;/td>
 &lt;td>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>liver cancer&lt;/td>
 &lt;td>&lt;a href="/posts/liver-cancer-half-as-likely-if-high-level-of-vitamin-d">Liver cancer half as likely if high level of vitamin D – Feb 2014&lt;/a>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>gallbladder cancer&lt;/td>
 &lt;td>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>pancreatic cancer&lt;/td>
 &lt;td>&lt;a href="/posts/cancer-pancreatic">Cancer - Pancreatic&lt;/a>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>thyroid cancer&lt;/td>
 &lt;td>&lt;a href="/posts/overview-thyroid-and-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Overview Thyroid and Vitamin D">Overview Thyroid and Vitamin D&lt;/a>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>ovarian cancer&lt;/td>
 &lt;td>&lt;a href="/posts/cancer-ovarian">Cancer - Ovarian&lt;/a>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>meningioma, a usually benign&lt;br> type of brain cancer;&lt;/td>
 &lt;td>&lt;a href="/posts/brain-cancer-in-175-countries-related-to-low-uvb-and-low-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Brain cancer in 175 countries related to low UVB and low vitamin D – Oct 2010">Brain cancer in 175 countries related to low UVB and low vitamin D – Oct 2010&lt;/a>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>multiple myeloma, a blood cancer&lt;/td>
 &lt;td>&lt;a href="/posts/multiple-myeloma-blood-cell-cancer-treated-by-vitamin-d-many-studies">Multiple Myeloma (blood cell cancer) treated by vitamin D - many studies&lt;/a>&lt;/td>
 &lt;/tr>
 &lt;/tbody>
&lt;/table>
&lt;p>&lt;strong>&lt;a href="http://www.nejm.org/doi/full/10.1056/NEJMsr1606602">Publisher wants $20 for the study&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Cancer and Vitamin D – PhD dissertation 2015</title><link>/posts/cancer-and-vitamin-d-phd-dissertation-2015.html</link><pubDate>Thu, 04 Aug 2016 00:00:00 +0000</pubDate><guid>/posts/cancer-and-vitamin-d-phd-dissertation-2015.html</guid><description/></item><item><title>Vitamin D and cancer – epidemiological association with colon and breast</title><link>/posts/vitamin-d-and-cancer-epidemiological-association-with-colon-and-breast.html</link><pubDate>Sat, 28 May 2016 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-cancer-epidemiological-association-with-colon-and-breast.html</guid><description>&lt;h4 id="vitamin-d-and-cancer-an-overview-on-epidemiological-studies">Vitamin D and Cancer: An overview on Epidemiological studies&lt;/h4>
&lt;p>Advances in Experimental Medicine and Biology 810:17-32 · September 2014&lt;/p>
&lt;p>José Manuel Ordóñez Mena1,2 and Hermann Brenner1,3&lt;/p>
&lt;p>1 Division of Clinical Epidemiology and Aging Research, German Cancer Research Centre, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany.E-Mail: 2 &lt;a href="mailto:jose.ordonezmena@dkfz.de">jose.ordonezmena@dkfz.de&lt;/a> ; 3 &lt;a href="mailto:hermann.brenner@dkfz.de">hermann.brenner@dkfz.de&lt;/a>&lt;/p>
&lt;p>In recent years, a rapidly increasing number of studies have investigated the relationship of vitamin D with total cancer and site-specific cancer obtaining diverse findings. In this chapter we provide an overview of epidemiological studies of vitamin D intake, 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D serum levels and vitamin D associated polymorphisms in relation to total and site-specific cancer risk. Overall, epidemiological evidence for total cancer is inconclusive.&lt;/p></description></item><item><title>Adaptive immunity (cancer, viruses, autoimmune) and vitamin D</title><link>/posts/adaptive-immunity-cancer-viruses-autoimmune-and-vitamin-d.html</link><pubDate>Sun, 24 Apr 2016 00:00:00 +0000</pubDate><guid>/posts/adaptive-immunity-cancer-viruses-autoimmune-and-vitamin-d.html</guid><description>&lt;h4 id="role-of-vitamin-d-in-cytotoxic-t-lymphocyte-immunity-to-pathogens-and-cancer">Role of vitamin D in cytotoxic T lymphocyte immunity to pathogens and cancer.&lt;/h4>
&lt;p>Crit Rev Clin Lab Sci. 2016 Apr;53(2):132-45. &lt;a href="https://doi.org/10.3109/10408363.2015.1094443.">doi: 10.3109/10408363.2015.1094443.&lt;/a> Epub 2015 Oct 19.&lt;/p>
&lt;p>Sarkar S1,2, Hewison M3, Studzinski GP4, Li YC5, Kalia V1,2.&lt;/p>
&lt;p>1a Department of Pediatrics, Division of Hematology and Oncology , University of Washington School of Medicine , Seattle , WA , USA .&lt;/p>
&lt;p>2b Seattle Children&amp;rsquo;s Research Institute, Ben Towne Center for Childhood Cancer Research , Seattle , WA , USA .&lt;/p></description></item><item><title>If you were born after 1960 your risk of getting cancer is 1 in 2 if you do not get a lot of vitamin D</title><link>/posts/if-you-were-born-after-1960-your-risk-of-getting-cancer-is-1-in-2-if-you-do-not--ot-of-vitamin-d.html</link><pubDate>Sun, 10 Apr 2016 00:00:00 +0000</pubDate><guid>/posts/if-you-were-born-after-1960-your-risk-of-getting-cancer-is-1-in-2-if-you-do-not--ot-of-vitamin-d.html</guid><description/></item><item><title>Cancer risk and survival improved by increasing vitamin D or UVB</title><link>/posts/cancer-risk-and-survival-improved-by-increasing-vitamin-d-or-uvb.html</link><pubDate>Sat, 09 Apr 2016 00:00:00 +0000</pubDate><guid>/posts/cancer-risk-and-survival-improved-by-increasing-vitamin-d-or-uvb.html</guid><description>&lt;h4 id="roles-of-solar-uvb-and-vitamin-d-in-reducing-cancer-risk-and-increasing-survival">Roles of Solar UVB and Vitamin D in Reducing Cancer Risk and Increasing Survival&lt;/h4>
&lt;p>WILLIAM B. GRANT, &lt;a href="mailto:wbgrant@infionline.net">wbgrant@infionline.net&lt;/a>;&lt;/p>
&lt;p>Sunlight, Nutrition, and Health Research Center, San Francisco, CA, U.S.A.&lt;/p>
&lt;p>The present article reviews existing scientific evidence in support of the ultraviolet-B (UVB)–vitamin D–cancer hypothesis, now being in its 35th year. Literature evidence comes from geographical ecological and observational studies, two successful clinical trials, and an understanding of how vitamin D reduces risk of and increases survival from cancer. Each approach has its strengths and limitations, and considering findings from all of these approaches yields the best conclusions. There exist over 15 types of cancer for which UVB exposure and/or 25-hydroxyvitamin D &lt;span>[25(OH)D]&lt;/span> concentrations have been found associated with reduced risk.&lt;/p></description></item><item><title>Cancer risk reduced 65 percent by vitamin D levels greater than 40 nanograms</title><link>/posts/cancer-risk-reduced-65-percent-by-vitamin-d-levels-greater-than-40-nanograms.html</link><pubDate>Wed, 06 Apr 2016 00:00:00 +0000</pubDate><guid>/posts/cancer-risk-reduced-65-percent-by-vitamin-d-levels-greater-than-40-nanograms.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#159-citations-of-this-study-as-of-dec-2022">159 citations of this study as of Dec 2022&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="159-citations-of-this-study-as-of-dec-2022">159 citations of this study as of Dec 2022&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://scholar.google.com/scholar?cites=10766508281430724889&amp;amp;as_sdt=5,48&amp;amp;sciodt=0,48&amp;amp;hl=en">Google Scholar&lt;/a>&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>Review of Recent Advances in Understanding the Role of Vitamin D in Reducing Cancer Risk: Breast, Colorectal, Prostate, and Overall Cancer - GRANT - Jan 2020 &lt;a href="https://doi.org/10.21873/anticanres.13977">https://doi.org/10.21873/anticanres.13977&lt;/a>&lt;/li>
&lt;/ul></description></item><item><title>'Cancer Screening Has Never Saved Lives' (but Vitamin D supplementation does)</title><link>/posts/cancer-screening-has-never-saved-lives-but-vitamin-d-supplementation-does.html</link><pubDate>Tue, 12 Jan 2016 00:00:00 +0000</pubDate><guid>/posts/cancer-screening-has-never-saved-lives-but-vitamin-d-supplementation-does.html</guid><description>&lt;h4 id="greenmedinfohttpwwwgreenmedinfocomblogcancer-screening-has-never-saved-lives-bmj-study-concludes-1-jan-2016">&lt;a href="http://www.greenmedinfo.com/blog/cancer-screening-has-never-saved-lives-bmj-study-concludes-1">GreenMedInfo&lt;/a> Jan 2016&lt;/h4>
&lt;p>&lt;strong>Reporting on several studies including the latest in the British Medical Journal&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;a href="http://www.bmj.com/content/352/bmj.h6080%20">Why cancer screening has never been shown to “save lives”—and what we can do about it&lt;/a>&lt;/strong>&lt;/p>
&lt;p>(Includes audio)&lt;/p>
&lt;p>&amp;ldquo;Discrepancies between disease specific and overall mortality were found in direction or magnitude in seven of 12 randomised trials of cancer screening.8 Despite reductions in disease specific mortality in the majority of studies, overall mortality was unchanged or increased. &amp;quot;&lt;/p></description></item><item><title>Off topic – More money to be made in TREATING cancer than PREVENTING it – NYT</title><link>/posts/off-topic-more-money-to-be-made-in-treating-cancer-than-preventing-it-nyt.html</link><pubDate>Mon, 28 Dec 2015 00:00:00 +0000</pubDate><guid>/posts/off-topic-more-money-to-be-made-in-treating-cancer-than-preventing-it-nyt.html</guid><description>&lt;h4 id="why-preventing-cancer-is-not-the-priority-in-drug-developmenthttpwwwnytimescom20151229upshotwhy-preventing-cancer-is-not-the-priority-in-drug-developmenthtml_r0">&lt;a href="http://www.nytimes.com/2015/12/29/upshot/why-preventing-cancer-is-not-the-priority-in-drug-development.html?_r=0">Why Preventing Cancer Is Not the Priority in Drug Development&lt;/a>&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>“There’s more money to be made investing in drugs that will extend cancer patients’ lives by a few months than in drugs that would prevent cancer in the first place.”&lt;/p>
&lt;/li>
&lt;li>
&lt;p>“Developing drugs to treat late-stage disease is usually much faster than developing drugs to treat early-stage disease or prevention, because late-stage disease is aggressive and progresses rapidly. This allows companies to see results in clinical trials more quickly, even if those results are only small improvements in survival.”&lt;/p></description></item><item><title>Dog Cancer 4X more likely if low Vitamin D</title><link>/posts/dog-cancer-4x-more-likely-if-low-vitamin-d.html</link><pubDate>Sun, 22 Nov 2015 00:00:00 +0000</pubDate><guid>/posts/dog-cancer-4x-more-likely-if-low-vitamin-d.html</guid><description>&lt;h4 id="new-study-shows-dogs-with-low-vitamin-d-are-at-risk-for-cancerhttpwwwdogsnaturallymagazinecomnew-study-shows-dogs-with-low-vitamin-d-are-at-risk-for-cancer-dogsnaturally">&lt;a href="http://www.dogsnaturallymagazine.com/new-study-shows-dogs-with-low-vitamin-d-are-at-risk-for-cancer/">New Study Shows Dogs with Low Vitamin D Are At Risk For Cancer&lt;/a> DogsNaturally&lt;/h4>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/cancer-in-dogs---low-vitamin-d.jpg" alt="image" width="300">
&lt;p>&lt;strong>Some other factors that are known to decrease the ability to convert dietary vitamin D to 25-VitD:&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>Polyunsaturated fats can decrease the bioavailability of vitamin D&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Fluoride (which is present in many pet foods and water supplies)&lt;/p>
&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>decreases magnesium, which is an essential cofactor for vitamin D&lt;/p>
&lt;/blockquote>
&lt;ul>
&lt;li>
&lt;p>Strong magnetic fields can reduce vitamin D levels&lt;/p>
&lt;/li>
&lt;li>
&lt;p>PCBs increase the risk of deficiency by 3%&lt;/p></description></item><item><title>Vitamin D does not improve cancer survival much – when dose size, etc. is ignored</title><link>/posts/vitamin-d-does-not-improve-cancer-survival-much-when-dose-size-etc-is-ignored.html</link><pubDate>Mon, 12 Oct 2015 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-does-not-improve-cancer-survival-much-when-dose-size-etc-is-ignored.html</guid><description>&lt;h4 id="the-effect-of-pre-diagnostic-vitamin-d-supplementation-on-cancer-survival-in-women-a-cohort-study-within-the-uk-clinical-practice-research-datalink">The effect of pre-diagnostic vitamin D supplementation on cancer survival in women: a cohort study within the UK Clinical Practice Research Datalink&lt;/h4>
&lt;p>BMC Cancer 2015, 15:670 doi:10.1186/s12885-015-1684-0&lt;/p>
&lt;p>Mona Jeffreys1, Maria Theresa Redaniel12 &lt;a href="mailto:theresa.redaniel@bristol.ac.uk">theresa.redaniel@bristol.ac.uk&lt;/a> and Richard M. Martin134&lt;/p>
&lt;p>1 School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UK&lt;/p>
&lt;p>2 NIHR CLAHRC West, 9th Floor, Whitefriars, Lewins Mead, Bristol BS1 2NT, UK&lt;/p>
&lt;p>3 Medical Research Council/University of Bristol Integrated Epidemiology Unit, University of Bristol, Bristol, UK&lt;/p></description></item><item><title>The health benefits of vitamin K</title><link>/posts/the-health-benefits-of-vitamin-k.html</link><pubDate>Wed, 07 Oct 2015 00:00:00 +0000</pubDate><guid>/posts/the-health-benefits-of-vitamin-k.html</guid><description/></item><item><title>Cancer risk weakly associated with vitamin D-binding protein – meta-analysis</title><link>/posts/cancer-risk-weakly-associated-with-vitamin-d-binding-protein-meta-analysis.html</link><pubDate>Mon, 14 Sep 2015 00:00:00 +0000</pubDate><guid>/posts/cancer-risk-weakly-associated-with-vitamin-d-binding-protein-meta-analysis.html</guid><description>&lt;h4 id="meta-analysis-of-vitamin-d-binding-protein-and-cancer-risk">Meta-analysis of vitamin D-binding protein and cancer risk.&lt;/h4>
&lt;p>Cancer Epidemiol Biomarkers Prev. 2015 Sep 12. pii: cebp.0262.2015. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Tagliabue E1, Raimondi S2, Gandini S3.&lt;/p>
&lt;p>BACKGROUND:&lt;/p>
&lt;p>Epidemiologic evidence supported a role for vitamin D and vitamin D receptor (VDR) polymorphisms in cancer risk. Beyond VDR, the biological effects of vitamin D are mediated by the vitamin D binding protein (DBP), a key protein in vitamin D metabolism. Furthermore, the gene encoding the DBP (GC, Group-specific component) has an important role in vitamin D pathway. Several studies investigated DBP serological levels and GC polymorphisms in association with cancer risk with controversial results. Thus we carried out a meta-analysis to investigate these associations.&lt;/p></description></item><item><title>Vitamin D and receptor reduce carcinogenic effects of pollutants</title><link>/posts/vitamin-d-and-receptor-reduce-carcinogenic-effects-of-pollutants.html</link><pubDate>Wed, 15 Jul 2015 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-receptor-reduce-carcinogenic-effects-of-pollutants.html</guid><description>&lt;h4 id="role-of-vitamin-d-metabolism-and-activity-on-carcinogenesis">Role of Vitamin D Metabolism and Activity on Carcinogenesis&lt;/h4>
&lt;p>Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Volume 22, Number 3, 2015, pp. 129-137(9); DOI: &lt;a href="http://dx.doi.org/10.3727/096504015X14267282610894">http://dx.doi.org/10.3727/096504015X14267282610894&lt;/a>&lt;/p>
&lt;p>Wu, Xiayu; Zhou, Tao; Cao, Neng; Ni, Juan; Wang, Xu&lt;/p>
&lt;p>The vitamin D endocrine system regulates a broad variety of independent biological processes, and its deficiency is associated with rickets, bone diseases, diabetes, cardiovascular diseases, and tuberculosis. Cellular and molecular studies have also shown that it is implicated in the suppression of cancer cell invasion, angiogenesis, and metastasis. Sunlight exposure and consequent increased circulating levels of vitamin D are associated with reduced occurrence and a reduced mortality in different histological types of cancer, including those resident in the skin, prostate, breast, colon, ovary, kidney, and bladder. The vitamin D receptor (VDR) as a steroid hormone superfamily of nuclear receptors is highly expressed in epithelial cells at risk for carcinogenesis, providing a direct molecular link by which vitamin D status impacts on carcinogenesis. Because VDR expression is retained in many human tumors, vitamin D status may be an important modulator of cancer progression in persons living with cancer. The aim of this review is to highlight the relationship between vitamin D, VDR, and cancer, summarizing several mechanisms proposed to explain the potential protective effect of vitamin D against the development and progression of cancer.&lt;/p></description></item><item><title>Cancer treated better when active vitamin d (calcitriol) is inside of PLGA nanoparticles</title><link>/posts/cancer-treated-better-when-active-vitamin-d-calcitriol-is-inside-of-plga-nanoparticles.html</link><pubDate>Wed, 24 Jun 2015 00:00:00 +0000</pubDate><guid>/posts/cancer-treated-better-when-active-vitamin-d-calcitriol-is-inside-of-plga-nanoparticles.html</guid><description>&lt;h4 id="plga-nanoparticles-as-a-platform-for-vitamin-d-based-cancer-therapy">PLGA nanoparticles as a platform for vitamin D-based cancer therapy&lt;/h4>
&lt;p>Beilstein J. Nanotechnol. 2015, 6, 1306–1318. doi:10.3762/bjnano.6.135&lt;/p>
&lt;p>Maria J. Ramalho, Joana A. Loureiro, Bárbara Gomes, Manuela F. Frasco, Manuel A. N. Coelho and M. Carmo Pereira &lt;a href="mailto:mcsp@fe.up.pt">mcsp@fe.up.pt&lt;/a>&lt;/p>
&lt;p>LEPABE, Department of Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/plga-f2.jpg" alt="image" width="500">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/plga-f4.jpg" alt="image" width="500">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/plga-f5c.jpg" alt="image" width="500">
&lt;p>Poly(lactic-co-glycolic acid) (PLGA) nanoparticles were studied as drug delivery vehicles for calcitriol, the active form of vitamin D3. In vitro effects of calcitriol encapsulated in PLGA nanoparticles were evaluated with respect to free calcitriol on human pancreatic cell lines, S2-013 and hTERT-HPNE, and the lung cancer cell line A549. Encapsulated calcitriol retained its biological activity, reducing the cell growth. Cytotoxicity assays demonstrated that encapsulation of calcitriol enhanced its inhibitory effect on cell growth at a concentration of 2.4 μM for the S2-013 cells (91%) and for A549 cells (70%) comparared to the free calcitriol results. At this concentration the inhibitory effect on nontumor cells (hTERT-HPNE) decreased to 65%. This study highlights the ability of PLGA nanoparticles to deliver vitamin D3 into cancer cells, with major effects regarding cancer cell cycle arrest and major changes in the cell morphological features.&lt;/p></description></item><item><title>How active vitamin D (Calcitriol) deals with cancer</title><link>/posts/how-active-vitamin-d-calcitriol-deals-with-cancer.html</link><pubDate>Wed, 24 Jun 2015 00:00:00 +0000</pubDate><guid>/posts/how-active-vitamin-d-calcitriol-deals-with-cancer.html</guid><description>&lt;h4 id="mechanistic-effects-of-calcitriol-in-cancer-biology">Mechanistic Effects of Calcitriol in Cancer Biology.&lt;/h4>
&lt;p>Nutrients. 2015 Jun 19;7(6):5020-5050.&lt;/p>
&lt;p>Díaz L1, Díaz-Muñoz M2, García-Gaytán AC3, Méndez I4.&lt;/p>
&lt;p>1Departamento de Biología de la Reproducción, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, Tlalpan, Mexico City 14000, Mexico. &lt;a href="mailto:lorenzadiaz@gmail.com">lorenzadiaz@gmail.com&lt;/a>.&lt;/p>
&lt;p>2Departamento de Neurobiología Celular y Molecular, Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM), Campus UNAM-Juriquilla, Blvd. Juriquilla 3001, Querétaro 76230, Mexico. &lt;a href="mailto:mdiaz@comunidad.unam.mx">mdiaz@comunidad.unam.mx&lt;/a>.&lt;/p>
&lt;p>3Departamento de Neurobiología Celular y Molecular, Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM), Campus UNAM-Juriquilla, Blvd. Juriquilla 3001, Querétaro 76230, Mexico. &lt;a href="mailto:acgarciag02@gmail.com">acgarciag02@gmail.com&lt;/a>.&lt;/p></description></item><item><title>Cancer - far less for outdoor workers</title><link>/posts/cancer-far-less-for-outdoor-workers.html</link><pubDate>Wed, 10 Jun 2015 00:00:00 +0000</pubDate><guid>/posts/cancer-far-less-for-outdoor-workers.html</guid><description>&lt;h3 id="male-nordic-smokers">Male Nordic Smokers&lt;/h3>
&lt;table>
 &lt;thead>
 &lt;tr>
 &lt;th>&lt;/th>
 &lt;th>&lt;/th>
 &lt;/tr>
 &lt;/thead>
 &lt;tbody>
 &lt;tr>
 &lt;td>Occupation&lt;/td>
 &lt;td>Standardized &lt;br>incidence rate&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>Waiters&lt;/td>
 &lt;td>1.48&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>Beverage workers&lt;/td>
 &lt;td>1.27&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>Tobacco workers&lt;/td>
 &lt;td>1.23&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>Seamen&lt;/td>
 &lt;td>1.22&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>Teachers&lt;/td>
 &lt;td>0.88&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>Gardeners&lt;/td>
 &lt;td>0.85&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>Forestry workers&lt;/td>
 &lt;td>0.84&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>Farmers&lt;/td>
 &lt;td>0.83&lt;/td>
 &lt;/tr>
 &lt;/tbody>
&lt;/table>
&lt;p>Grant WB.&lt;/p>
&lt;p>Role of solar UV irradiance and smoking in cancer as inferred from cancer incidence rates by occupaton in Nordic countries.&lt;/p>
&lt;p>Dermatoendocrinol. 2012;4(2): 203M11.&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/grant-cancer-2012.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;hr>
&lt;h4 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-and-cancer-special-issue">Vitamin D and Cancer – Special issue Jan 2013&lt;/a>&lt;/p></description></item><item><title>Obesity causes 20 percent of all cancer, low vitamin D may be the connection – meta-analysis</title><link>/posts/obesity-causes-20-percent-of-all-cancer-low-vitamin-d-may-be-the-connection-meta-analysis.html</link><pubDate>Sun, 31 May 2015 00:00:00 +0000</pubDate><guid>/posts/obesity-causes-20-percent-of-all-cancer-low-vitamin-d-may-be-the-connection-meta-analysis.html</guid><description>&lt;h4 id="40-citations-of-this-study-as-of-june-2021httpsscholargooglecomscholarcites7380104615790965503as_sdt548sciodt048hlen">&lt;a href="https://scholar.google.com/scholar?cites=7380104615790965503&amp;amp;as_sdt=5,48&amp;amp;sciodt=0,48&amp;amp;hl=en">40 citations of this study as of June 2021&lt;/a>&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>The Pleiotropic Effects of Vitamin D in Gynaecological and Obstetric Diseases: An Overview on a Hot Topic - 2015 &lt;a href="https://doi.org/10.1155/2015/986281">https://doi.org/10.1155/2015/986281&lt;/a> FREE PDF&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Vitamin D, Advanced Colorectal Cancer and High BMI: Is Obesity A Triple Agent? - 2021 Master thesis &lt;a href="https://fse.studenttheses.ub.rug.nl/23795/">https://fse.studenttheses.ub.rug.nl/23795/&lt;/a> PDF not available&lt;/p>
&lt;/li>
&lt;/ul>
&lt;/div>
&lt;p>BACKGROUND:&lt;/p>
&lt;p>It is estimated that 20% of all cancer cases are caused by obesity. Vitamin D is thought to be one of the mechanisms underlying this association. This review aims to summarise the evidence for the mediating effect of vitamin D on the link between obesity and cancer.&lt;/p></description></item><item><title>Opioid use in palliative cancer patients far less if high level of vitamin D</title><link>/posts/opioid-use-in-palliative-cancer-patients-far-less-if-high-level-of-vitamin-d.html</link><pubDate>Wed, 27 May 2015 00:00:00 +0000</pubDate><guid>/posts/opioid-use-in-palliative-cancer-patients-far-less-if-high-level-of-vitamin-d.html</guid><description>&lt;h4 id="low-vitamin-d-levels-are-associated-with-higher-opioid-dose-in-palliative-cancer-patients--results-from-an-observational-study-in-sweden">Low Vitamin D Levels Are Associated with Higher Opioid Dose in Palliative Cancer Patients – Results from an Observational Study in Sweden&lt;/h4>
&lt;p>PLOS ONE May 27, 2015DOI: 10.1371/journal.pone.0128223&lt;/p>
&lt;p>Peter Bergman, Susanne Sperneder, Jonas Höijer, Jenny Bergqvist, Linda Björkhem-Bergman&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/opiad-vs-vit-d.jpg" alt="image" width="400">
&lt;p>Background&lt;/p>
&lt;p>Vitamin D deficiency is common among palliative cancer patients and has been connected to an increased risk for pain, depressions and infections. Therefore we wanted to test the hypothesis that low 25-hydroxyvitamin D (25OHD) levels are associated with higher opioid dose, higher infectious burden and impaired quality of life in palliative cancer patients. The secondary aim was to investigate the association between 25OHD-levels and survival time.&lt;/p></description></item><item><title>Cancer deaths strongly related to low vitamin D if sampled near time of diagnosis</title><link>/posts/cancer-deaths-strongly-related-to-low-vitamin-d-if-sampled-near-time-of-diagnosis.html</link><pubDate>Sat, 18 Apr 2015 00:00:00 +0000</pubDate><guid>/posts/cancer-deaths-strongly-related-to-low-vitamin-d-if-sampled-near-time-of-diagnosis.html</guid><description>&lt;h4 id="serum-levels-of-25-hydroxyvitamin-d-and-survival-in-norwegian-patients-with-cancer-of-breast-colon-lung-and-lymphoma-a-population-based-study">Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study.&lt;/h4>
&lt;p>Cancer Causes Control. 2012 Feb;23(2):363-70. &lt;a href="https://doi.org/10.1007/s10552-011-9885-6.">doi: 10.1007/s10552-011-9885-6.&lt;/a>&lt;/p>
&lt;p>Tretli S1, Schwartz GG, Torjesen PA, Robsahm TE.&lt;/p>
&lt;p>1The Cancer Registry of Norway, Institute of Population-based Cancer Research, Majorstuen, 0304 Oslo, Norway. &lt;a href="mailto:steinar.tretli@kreftregisteret.no">steinar.tretli@kreftregisteret.no&lt;/a>&lt;/p>
&lt;p>PURPOSE:&lt;/p>
&lt;p>We investigated the association between serum levels of 25-hydroxyvitamin D (25-OHD) and risk of death in Norwegian cancer patients.&lt;/p>
&lt;p>METHODS:&lt;/p></description></item><item><title>Cancer deaths of senior women 60 percent more likely if low Vitamin D</title><link>/posts/cancer-deaths-of-senior-women-60-percent-more-likely-if-low-vitamin-d.html</link><pubDate>Sun, 08 Mar 2015 00:00:00 +0000</pubDate><guid>/posts/cancer-deaths-of-senior-women-60-percent-more-likely-if-low-vitamin-d.html</guid><description>&lt;h4 id="vitamin-d-and-cancer-mortality-in-elderly-women">Vitamin D and cancer mortality in elderly women&lt;/h4>
&lt;p>Germaine Wong 123 &lt;a href="mailto:germaine.wong@health.nsw.gov.au">germaine.wong@health.nsw.gov.au&lt;/a>, Wai Hon Lim 45, Joshua Lewis 46, Jonathan C Craig 12, Robin Turner 2, Kathy Zhu 46, Ee Mun Lim 7 and Richard Prince 46&lt;/p>
&lt;p>BMC Cancer 2015, 15:106 doi:10.1186/s12885-015-1112-5, Published: 8 March 2015&lt;/p>
&lt;p>Background There is increasing evidence that vitamin D deficiency is a risk factor for cancer, however it remains uncertain whether vitamin D deficiency also predisposes to death from cancer. The aim of the study was to determine the association between serum 25-hydroxy-vitamin D (25 (OH) D) concentrations and cancer-specific mortality in a community-based cohort of older post-menopausal women.&lt;/p></description></item><item><title>Photodynamic Therapy used to kill cancer in mice was improved 4X by Vitamin D</title><link>/posts/photodynamic-therapy-used-to-kill-cancer-in-mice-was-improved-4x-by-vitamin-d.html</link><pubDate>Fri, 06 Mar 2015 00:00:00 +0000</pubDate><guid>/posts/photodynamic-therapy-used-to-kill-cancer-in-mice-was-improved-4x-by-vitamin-d.html</guid><description>&lt;h4 id="vitamin-d-enhances-the-efficacy-of-photodynamic-therapy-in-a-murine-model-of-breast-cancer">Vitamin D enhances the efficacy of photodynamic therapy in a murine model of breast cancer&lt;/h4>
&lt;p>Kishore R. Rollakanti 1,2, Sanjay Anand 2,3 andEdward V. Maytin 1,2,3,*&lt;/p>
&lt;p>Cancer Medicine: online: 25 FEB 2015, DOI: 10.1002/cam4.361&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;p>Chemicals are put into bloodstream which attach themselves to cancerous cells&lt;/p>
&lt;p>A laser (633 nm = red) is used to activate those chemicals to kill a wide variety of cancerous cells.&lt;/p>
&lt;p>This is called Photodynamic Therapy (PDT)&lt;/p></description></item><item><title>Cancer – will 4,000 IU of vitamin D daily help in one month (no) – VIDAFACT</title><link>/posts/cancer-will-4000-iu-of-vitamin-d-daily-help-in-one-month-no-vidafact.html</link><pubDate>Wed, 31 Dec 2014 00:00:00 +0000</pubDate><guid>/posts/cancer-will-4000-iu-of-vitamin-d-daily-help-in-one-month-no-vidafact.html</guid><description>&lt;h4 id="the-effect-on-quality-of-life-of-vitamin-d-administration-for-advanced-cancer-treatment-vidafact-study-protocol-of-a-randomised-controlled-trial">The effect on quality of life of vitamin D administration for advanced cancer treatment (VIDAFACT study): protocol of a randomised controlled trial&lt;/h4>
&lt;p>BMJ Open 2014;4:e006128 doi:10.1136/bmjopen-2014-006128&lt;/p>
&lt;p>Montserrat Martinez-Alonso1,2, Adriana Dusso3, Gemma Ariza4, Maria Nabal5&lt;/p>
&lt;p>1Ciències Mèdiques Bàsiques, Universitat de Lleida, Lleida, Spain&lt;/p>
&lt;p>2Biostatistics and Methodological Support, IRBLLEIDA, Lleida, Spain&lt;/p>
&lt;p>3Experimental Nephrology, IRBLLEIDA, Lleida, Spain&lt;/p>
&lt;p>4Rehabilitation Unit, Hospital Universitari Arnau de Vilanova, Lleida, Spain&lt;/p>
&lt;p>5Palliative Care Supportive Team, Hospital Universitari Arnau de Vilanova, Lleida, Spain&lt;/p></description></item><item><title>Cancer and active Vitamin D – in Spanish</title><link>/posts/cancer-and-active-vitamin-d-in-spanish.html</link><pubDate>Fri, 14 Nov 2014 00:00:00 +0000</pubDate><guid>/posts/cancer-and-active-vitamin-d-in-spanish.html</guid><description>&lt;h4 id="spanvitamin-d-and-cancer-antineoplastic-effects-of-1α25oh2-vitamin-d3span">&lt;span>[Vitamin D and cancer: antineoplastic effects of 1α,25(OH)2-vitamin D3]&lt;/span>.&lt;/h4>
&lt;p>Medicina (B Aires). 2012;72(2):143-9. &lt;span>[Article in Spanish]&lt;/span>&lt;/p>
&lt;p>González Pardo V1, Boland R, Russo de Boland A.&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/cancer-spanish.jpg" alt="image">
&lt;p>The hormonal form of vitamin D, 1α,25(OH)2-vitamin D3 (1α,25(OH)2D3), in addition of playing a central role in the control of calcium homeostasis in the body, regulates the growth and differentiation of different cell types, including cancer cells. At present several epidemiologic and clinical studies investigate the effect of the hormone in these cells due to the interest in the therapeutic use of 1α,25(OH)2D3 and analogues with less calcemic activity for prevention or treatment of cancer. This review describes vitamin D endocrine system, its mechanism of action, its antineoplastic activity and provides information about the latest advances in the study of new hormone analogues with less calcemic activity for cancer treatment.&lt;/p></description></item><item><title>Cancer, Sunlight, and Vitamin D - Holick</title><link>/posts/cancer-sunlight-and-vitamin-d-holick.html</link><pubDate>Sun, 05 Oct 2014 00:00:00 +0000</pubDate><guid>/posts/cancer-sunlight-and-vitamin-d-holick.html</guid><description>&lt;p>Journal of Clinical &amp;amp; Translational Endocrinology (2014), &lt;a href="https://doi.org/10.1016/j.jcte.2014.10.001.">doi: 10.1016/j.jcte.2014.10.001.&lt;/a>&lt;/p>
&lt;p>Michael F. Holick,&lt;/p>
&lt;p>Section of Endocrinology, Diabetes, and Nutrition, Department of Medicine, Boston University Medical Center, 02118&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/sunlight-cancer-holick.pdf">Download the PDF from VitaminDWiki.&lt;/a>&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#abstract">Abstract&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#physiology-and-metabolism-of-vitamin-d">Physiology and Metabolism of Vitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#association-studies-linking-sun-exposure-and-vitamin-d-status-with-cancer-risk">Association Studies Linking Sun Exposure and Vitamin D Status with Cancer Risk&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-vitamin-d-sunlight-and-cancer-conundrum">The Vitamin D, Sunlight and Cancer Conundrum&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-importance-of-maintaining-a-healthy-vitamin-d-status-to-reduce-risk-of-cancer">The Importance of Maintaining a Healthy Vitamin D Status to Reduce Risk of Cancer&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#approaches-for-raising-blood-levels-of-25-hydroxyvitamin-d">Approaches for Raising Blood Levels of 25-hydroxyvitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-toxicity">Vitamin D Toxicity&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#conclusion">Conclusion&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h4 id="abstract">Abstract&lt;/h4>
&lt;p>The sunshine vitamin has been associated with reduced risk for many chronic illnesses including cancer and cancer mortality. Epidemiologic and ecological studies have suggested that living at higher latitudes and having lower blood levels of 25-hydroxyvitamin D are associated with increased risk for up to 15 cancers including breast, colon, lung, lymphoma, pancreatic, ovarian and prostate cancer. Most randomized controlled trials using appropriate doses of vitamin D have suggested that improvement in vitamin D status reduces risk for several cancers. Although the exact mechanism by which enhanced vitamin D status reduces risk for cancer is not completely understood, there is evidence that by raising blood levels of 25-hydroxyvitamin D this metabolite can enter a wide variety of cells in the body and then be converted to 1,25- dihydroxyvitamin D3. The vitamin D metabolite, 1,25-dihydroxyvitamin D3, has been demonstrated to markedly reduce cellular proliferation especially of malignant cells that have a vitamin D receptor. It also induces terminal differentiation. 1,25-dihydroxyvitamin D3 is also anti-angiogenic and pro-apoptotic which also plays a role in reducing the growth and spread of malignant cells. Thus improvement in vitamin D status with sensible sun exposure, vitamin D supplementation and ingesting foods containing vitamin D is a reasonable strategy to reduce risk of malignancy.&lt;/p></description></item><item><title>Off Topic: Cannabinoids as Cancer chemotherapy</title><link>/posts/off-topic-cannabinoids-as-cancer-chemotherapy.html</link><pubDate>Wed, 01 Oct 2014 00:00:00 +0000</pubDate><guid>/posts/off-topic-cannabinoids-as-cancer-chemotherapy.html</guid><description>&lt;h3 id="update-off-topic-cannabis-and-disease-studies-at-greenmedinfo--dec-2015postsoff-topic-cannabis-and-disease-studies-at-greenmedinfo">Update: &lt;a href="/posts/off-topic-cannabis-and-disease-studies-at-greenmedinfo">Off topic: Cannabis and disease studies at GreenMedInfo – Dec 2015&lt;/a>&lt;/h3>
&lt;h4 id="the-cannabis-cure-for-cancerhttpwwwgreenmedinfocomblogcannabis-cure-cancer20-greenmedinfo">&lt;a href="http://www.greenmedinfo.com/blog/cannabis-cure-cancer%20">The Cannabis Cure For Cancer&lt;/a> GreenMedInfo&lt;/h4>
&lt;p>Dr. Mark Sircus has also written an ebook: &lt;a href="http://drsircus.com/books/e-book/medical-marijuana/%20">Medical Marijuana&lt;/a> updated April 2014&lt;/p>
&lt;h4 id="summary-of-how-cannabinoids-works">Summary of how Cannabinoids works&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>Triggering cell death, through a mechanism called apoptosis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Stopping cells from dividing&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Preventing new blood vessels from growing into tumours&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Reducing the chances of cancer cells spreading through the body,&lt;/p>
&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>by stopping cells from moving or invading neighbouring tissue&lt;/p></description></item><item><title>Obesity increases Cancer - perhaps due to low vitamin D - many articles</title><link>/posts/obesity-increases-cancer-perhaps-due-to-low-vitamin-d-many-articles.html</link><pubDate>Thu, 25 Sep 2014 00:00:00 +0000</pubDate><guid>/posts/obesity-increases-cancer-perhaps-due-to-low-vitamin-d-many-articles.html</guid><description>&lt;p>&lt;strong>VitaminDWiki observation&lt;/strong>&lt;/p>
&lt;p>Obesity ==&amp;gt; reduces the level of vitamin D avaiable in the blood&lt;/p>
&lt;p>Obesity ==&amp;gt; outdoors less ==&amp;gt; decreases vitamin D from the sun&lt;/p>
&lt;p>Low vitamin D ==&amp;gt; Increased Cancer&lt;/p>
&lt;hr>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#high-bmi-in-late-teens-linked-to-higher-risk-of-17-different-cancers-later-in-life---nov-2023">High BMI in late teens linked to higher risk of 17 different cancers later in life - Nov 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#obesity-linked-to-13-cancers-the-linkage-is-probably-vitamin-d--aug-2016">Obesity linked to 13 cancers, the linkage is probably vitamin D – Aug 2016&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#obesity-causes-20-percent-of-all-cancer-low-vitamin-d-may-be-the-connection--meta-analysis---sept-2014">Obesity causes 20 percent of all cancer, low vitamin D may be the connection – meta-analysis - Sept 2014&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#association-between-obesity-and-ovarian-cancer---spanish---may-2014">Association between obesity and ovarian cancer - Spanish - May 2014&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#obesity-increases-risk-of-cancer---perhaps-vitamin-d---aug-2010">Obesity increases risk of cancer - perhaps vitamin D - Aug 2010&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#bmi-associated-with-36-of-new-cancer---lancet-2014-not-mention-vitamin-d">BMI associated with 3.6% of new Cancer - Lancet 2014 (not mention vitamin D)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#bmi-and-cancer-aug-2014-lancet-not-mention-low-vitamin-d">BMI and Cancer Aug 2014 Lancet (not mention low vitamin D)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#it-appears-that-a-hrefpostsvitamin-d-restricts-new-capillary-growth-angiogenesis-in-fat-and-cancers-stylecolor-red-text-decoration-underline-titlethis-postcategory-does-not-exist-yet-vitamin-d-restricts-new-capillary-growth-angiogenesis-in-fat-and-cancersvitamin-d-restricts-new-capillary-growth-angiogenesis-in-fat-and-cancersa">It appears that &lt;a href="/posts/vitamin-d-restricts-new-capillary-growth-angiogenesis-in-fat-and-cancers" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Vitamin D restricts new capillary growth (angiogenesis) in fat and cancers">Vitamin D restricts new capillary growth (angiogenesis) in fat and cancers&lt;/a>&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="high-bmi-in-late-teens-linked-to-higher-risk-of-17-different-cancers-later-in-life---nov-2023">High BMI in late teens linked to higher risk of 17 different cancers later in life - Nov 2023&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://www.trialsitenews.com/a/high-bmi-in-late-teens-linked-to-higher-risk-of-17-different-cancers-later-in-life-af5f6251">TrialSiteNews&lt;/a>&lt;br>
Note: These were men who were conscripted by the military, so were not very obese&lt;/strong>&lt;/p></description></item><item><title>Off topic: Oncologists paid 350 dollars per patient-month to use less effective and more toxic cancer drugs</title><link>/posts/off-topic-oncologists-paid-350-dollars-per-patient-month-to-use-less-effective-a-ic-cancer-drugs.html</link><pubDate>Sun, 14 Sep 2014 00:00:00 +0000</pubDate><guid>/posts/off-topic-oncologists-paid-350-dollars-per-patient-month-to-use-less-effective-a-ic-cancer-drugs.html</guid><description>&lt;h2 id="see-also-web">See also web&lt;/h2>
&lt;ul>
&lt;li>&lt;a href="http://clinicaltrials.gov/ct2/results?term=cancer&amp;amp;recr=&amp;amp;rslt=&amp;amp;type=&amp;amp;cond=&amp;amp;intr=%22vitamin+d%22&amp;amp;titles=&amp;amp;outc=&amp;amp;spons=&amp;amp;lead=&amp;amp;id=&amp;amp;state1=&amp;amp;cntry1=&amp;amp;state2=&amp;amp;cntry2=&amp;amp;state3=&amp;amp;cntry3=&amp;amp;locn=&amp;amp;gndr=&amp;amp;rcv_s=&amp;amp;rcv_e=&amp;amp;lup_s=&amp;amp;lup_e=">Cancer Intervention Trials with Vitamin D&lt;/a> 197 as of Sept 2014&lt;/li>
&lt;/ul></description></item><item><title>More vegetables or fish, less Cancer</title><link>/posts/more-vegetables-or-fish-less-cancer.html</link><pubDate>Tue, 15 Jul 2014 00:00:00 +0000</pubDate><guid>/posts/more-vegetables-or-fish-less-cancer.html</guid><description/></item><item><title>Dog Cancer (hemangiosarcoma) is rare if more than 100 ng of vitamin D</title><link>/posts/dog-cancer-hemangiosarcoma-is-rare-if-more-than-100-ng-of-vitamin-d.html</link><pubDate>Sun, 13 Jul 2014 00:00:00 +0000</pubDate><guid>/posts/dog-cancer-hemangiosarcoma-is-rare-if-more-than-100-ng-of-vitamin-d.html</guid><description>&lt;h4 id="serum-25-hydroxyvitamin-d-concentrations-in-dogs---correlation-with-health-and-cancer-risk">Serum 25-hydroxyvitamin D concentrations in dogs - correlation with health and cancer risk&lt;/h4>
&lt;p>Veterinary and Comparative Oncology,DOI:10.1111/vco.12101&lt;/p>
&lt;p>K. A. Selting1,C. R. Sharp2,R. Ringold3,D. H. Thamm4 and R. Backus1&lt;/p>
&lt;p>&amp;lsquo;Veterinary Medical Teaching Hospital, University of Missouri, Columbia, MO, USA&lt;/p>
&lt;p>2 Cummings School of Veterinary Medicine, Tufts University, North Grafton, MA, USA&lt;/p>
&lt;p>3 Veterinary Diagnostics Institute, Simi Valley, CA, USA&lt;/p>
&lt;p>4 Department of Clinical Sciences, Animal Cancer Center, Colorado State University, Fort Collins, CO, USA&lt;/p></description></item><item><title>Role of Vitamin D in human Diseases and Disorders – An Overview – DBP, VDR</title><link>/posts/role-of-vitamin-d-in-human-diseases-and-disorders-an-overview-dbp-vdr.html</link><pubDate>Sun, 29 Jun 2014 00:00:00 +0000</pubDate><guid>/posts/role-of-vitamin-d-in-human-diseases-and-disorders-an-overview-dbp-vdr.html</guid><description>&lt;p>International Journal of Pharmacological Research, Vol 4, No 2 (2014)&lt;/p>
&lt;p>Priyanshee Gohil, Palak Solanki&lt;/p>
&lt;p>Priyanshee Gohil, Assistant Professor, K.B.Institute of Pharmaceutical Education and Research, Gandhinagar, Gujarat, India&lt;/p>
&lt;p>Palak Solanki. Department of Pharmacology and Clinical Pharmacy, K. B. Instituteof Pharmaceutical Education &amp;amp; Research, Kadi SarvaVishvavidyalya, Gandhinagar.	 India&lt;/p>
&lt;p>Vitamin D is a fat soluble vitamin and generated in human skin by ultraviolet (UV) light. Today, vitamin D is considered to be a steroidal hormone and plays a central role in bone mineralization and calcium homeostasis. The active form of the vitamin D is 1, 25-dihydroxyvitamin D &lt;span>[1, 25-dihydroxycholecalciferol (DHCC)]&lt;/span> which mediates proliferation, differentiation and various functions at the cellular level through Vitamin D receptors (VDR).Therefore, compromised vitamin D status is likely to be involved in progression or pathogenesis of various disorders. This assumption is consistent with findings from epidemiological studies that a compromised vitamin D status in humans increases the risk of autoimmune diseases, such as inflammatory bowel disease, rheumatoid arthritis, systemic lupus erythematosus (SLE), multiple sclerosis and type I diabetes mellitus. However, diseases like cancer, cardiovascular disorders and bone disorders are yet not focused. Thus the role of vitamin D in pathogenesis of various diseases is complex and controversial. This review briefly summarizes the role of vitamin D in development and progression of different human disorders.&lt;/p></description></item><item><title>Cancer incidence not reduced by 1100 IU of vitamin D (proven again) but mortality decreased</title><link>/posts/cancer-incidence-not-reduced-by-1100-iu-of-vitamin-d-proven-again-but-mortality-decreased.html</link><pubDate>Tue, 17 Jun 2014 00:00:00 +0000</pubDate><guid>/posts/cancer-incidence-not-reduced-by-1100-iu-of-vitamin-d-proven-again-but-mortality-decreased.html</guid><description>&lt;h3 id="vitamin-d-supplements-and-cancer-incidence-and-mortality-a-meta-analysis">Vitamin D supplements and cancer incidence and mortality: a meta-analysis&lt;/h3>
&lt;p>British Journal of Cancer , (10 June 2014) | doi:10.1038/bjc.2014.294&lt;/p>
&lt;p>N Keum and E Giovannucci&lt;/p>
&lt;p>Background:&lt;/p>
&lt;p>Observational studies suggest that effects of vitamin D may be stronger for cancer mortality than for incidence. Yet, existing randomised controlled trials (RCTs) of vitamin D supplementation have limited power to examine the relationships as their primary end points are not cancer incidence or mortality.&lt;/p></description></item><item><title>Less intestinal cancer in mice if add vitamin D, but even less with ultraviolet light</title><link>/posts/less-intestinal-cancer-in-mice-if-add-vitamin-d-but-even-less-with-ultraviolet-light.html</link><pubDate>Thu, 05 Jun 2014 00:00:00 +0000</pubDate><guid>/posts/less-intestinal-cancer-in-mice-if-add-vitamin-d-but-even-less-with-ultraviolet-light.html</guid><description>&lt;h4 id="uv-exposure-inhibits-intestinal-tumor-growth-and-progression-to-malignancy-in-intestine-specific-apc-mutant-mice-kept-on-low-vitamin-d-diet">UV exposure inhibits intestinal tumor growth and progression to malignancy in intestine-specific Apc mutant mice kept on low vitamin D diet.&lt;/h4>
&lt;p>Int J Cancer. 2014 May 29. &lt;a href="https://doi.org/10.1002/ijc.29002">doi: 10.1002/ijc.29002&lt;/a>&lt;/p>
&lt;p>Rebel H1, der Spek CD, Salvatori D, van Leeuwen JP, Robanus-Maandag EC, de Gruijl FR.&lt;/p>
&lt;p>Mortality from colorectal cancer increases with latitude and decreases with ambient UV radiation. We investigated whether moderate UV dosages could inhibit intestinal tumor development and whether this corresponded with UV-induced vitamin D. FabplCre;Apc15lox/+ mice, which develop &lt;strong>intestinal tumors&lt;/strong> , and their parents were put on a vitamin D-deficient diet. Next to a control group, one group was vitamin D supplemented and another one group was daily UV irradiated from 6 weeks of age. Vitamin D statuses after 6 weeks of treatment were markedly increased: mean ± SD from 7.7 ± 1.9 in controls to 75 ± 15 nmol/l with vitamin D supplementation (no gender difference), and to 31 ± 13 nmol/l in males and 85 ± 17 nmol/l in females upon UV irradiation. The tumor load (area covered by tumors) at 7.5 months of age was significantly reduced in both the vitamin D-supplemented group (130 ± 25 mm2 , p = 0.018) and the UV-exposed group (88 ± 9 mm2 , p &amp;lt; 0.0005; no gender differences) compared to the control group (202 ± 23 mm2 ). No reductions in tumor numbers were found. Only UV exposure appeared to reduce progression to malignancy (p = 0.014). Our experiments clearly demonstrate for the first time an inhibitory effect of moderate UV exposure on outgrowth and malignant progression of primary intestinal tumors, which at least in part can be attributed to vitamin D.&lt;/p></description></item><item><title>Cancer Council of Australia recommends 30 minutes of daily sunshine</title><link>/posts/cancer-council-of-australia-recommends-30-minutes-of-daily-sunshine.html</link><pubDate>Mon, 02 Jun 2014 00:00:00 +0000</pubDate><guid>/posts/cancer-council-of-australia-recommends-30-minutes-of-daily-sunshine.html</guid><description>&lt;h3 id="cancer-councilhttpwwwcancerorgaupreventing-cancersun-protectionvitamin-d">&lt;a href="http://www.cancer.org.au/preventing-cancer/sun-protection/vitamin-d/">Cancer Council&lt;/a>&lt;/h3>
&lt;p>&lt;strong>&lt;a href="http://www.nbnnews.com.au/index.php/2014/06/02/cancer-council-launches-vitamin-d-campaign/">NBN news has a short podcast (audio only)&lt;/a>&lt;/strong>&lt;/p>
&lt;p>Which is also available at the bottom of this page&lt;/p>
&lt;p>Apparently NBN and this section of the Cancer Council is in the Southern portion of Australia - where the UVB is not so intense&lt;/p>
&lt;hr>
&lt;h2 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h2>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-research-leads-to-surprising-health-tip-australians-need-more-time-in-the-sun">Vitamin D research leads to surprising health tip – Australians need more time in the sun – May 2014&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-testing-and-levels-are-increasing-in-australia-nsw">Vitamin D testing AND levels are increasing in Australia (NSW) – May 2014&lt;/a>&lt;/p></description></item><item><title>Cancer survival 4 percent more likely with just a little more vitamin D (4 ng) - meta-analysis</title><link>/posts/cancer-survival-4-percent-more-likely-with-just-a-little-more-vitamin-d-4-ng-meta-analysis.html</link><pubDate>Thu, 01 May 2014 00:00:00 +0000</pubDate><guid>/posts/cancer-survival-4-percent-more-likely-with-just-a-little-more-vitamin-d-4-ng-meta-analysis.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#the-impacts-of-circulating-25-hydroxyvitamin-d-levels-on-cancer-patient-outcomes-a-systematic-review-and-meta-analysis">The Impacts of Circulating 25-Hydroxyvitamin D Levels on Cancer Patient Outcomes: A Systematic Review and Meta-Analysis.&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="the-impacts-of-circulating-25-hydroxyvitamin-d-levels-on-cancer-patient-outcomes-a-systematic-review-and-meta-analysis">The Impacts of Circulating 25-Hydroxyvitamin D Levels on Cancer Patient Outcomes: A Systematic Review and Meta-Analysis.&lt;/h4>
&lt;p>J Clin Endocrinol Metab. 2014 Apr 29:jc20134320.&lt;/p>
&lt;p>Li M1, Chen P, Li J, Chu R, Xie D, Wang H.&lt;/p>
&lt;p>1Key Laboratory of Food Safety Research (M.L., P.C., J.L., R.C., D.X., H.W.), Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, University of the Chinese Academy of Sciences, Shanghai 200031, China; Key Laboratory of Food Safety Risk Assessment (D.X., H.W.), Ministry of Health, Beijing 100021, China; and School of Life Science and Technology (D.X., H.W.), Shanghai Tech University, Shanghai, 200031, China.&lt;/p></description></item><item><title>Vitamin D Receptor role in Autoimmune Diseases and or cancers</title><link>/posts/vitamin-d-receptor-role-in-autoimmune-diseases-and-or-cancers.html</link><pubDate>Sun, 12 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-receptor-role-in-autoimmune-diseases-and-or-cancers.html</guid><description>&lt;h4 id="distilling-the-genetics-of-the-vitamin-d-receptor-to-understand-the-controversies-over-beneficial-effects-of-vitamin-d-in-autoimmune-diseases-andor-cancers">Distilling the Genetics of the Vitamin D Receptor to Understand the Controversies over Beneficial Effects of Vitamin D in Autoimmune Diseases and/or Cancers&lt;/h4>
&lt;p>Human Genet Embryol 2013, 3:3 &lt;a href="http://dx.doi.org/10.4172/2161-0436.1000e110">http://dx.doi.org/10.4172/2161-0436.1000e110&lt;/a>&lt;/p>
&lt;p>Yue Zhang &lt;a href="mailto:zhanglee2006@gmail.com">zhanglee2006@gmail.com&lt;/a> Department of Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Notre-Dame Hospital, Montreal, Quebec H2L 4M1, Canada&lt;/p>
&lt;h3 id="primer">Primer&lt;/h3>
&lt;p>Decoding the genetics of an increased risk of complex diseases such as Autoimmune Diseases (ADs) and/or cancers associated with the aging process remains challenging. The controversies exist for the beneficial effects of vitamin D supplementation on these diseases &lt;sup>[1,2]&lt;/sup>. However, based on comparative advantages of different model systems and recent ChIP-seq/ChIP-chip studies, we distilled out one novel testable hypothesis as follows: the genetic regulatory network of vitamin D receptor (VDR, the homologue of Caenorhabditis elegans DAF-12) may play a central role as a common basis preventing some autoimmune diseases and associated cancers &lt;sup>[3]&lt;/sup>. Further, as a capacitor, DAF-12/VDR may buffer polygenic genetic mutations and/ or variations. The highly-conserved targets (e.g. MMP3) of DAF-12/ VDR may have synergic functions with its other evolutionarily-&amp;ldquo;fresh&amp;rdquo; targets (e.g. IL-6). Being consistent with the &amp;ldquo;hygiene hypothesis&amp;rdquo; and the &amp;ldquo;danger signals&amp;rdquo; theory, some VDR/DAF-12 targets may be involved in these processes. In nature, the reversal of diseased status with vitamin D supplementation could be more difficult and/or complex than the breakdown of robust health. Put aggregates, they may partially clarify the controversies.&lt;/p></description></item><item><title>Vitamin D receptor polymorphisms are risk factors for various cancers – meta-analysis</title><link>/posts/vitamin-d-receptor-polymorphisms-are-risk-factors-for-various-cancers-meta-analysis.html</link><pubDate>Sat, 11 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-receptor-polymorphisms-are-risk-factors-for-various-cancers-meta-analysis.html</guid><description/></item><item><title>Vitamin D and Cancer at NIH</title><link>/posts/vitamin-d-and-cancer-at-nih.html</link><pubDate>Fri, 10 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-cancer-at-nih.html</guid><description>&lt;h2 id="vitamin-d-and-cancer-preventionhttpwwwcancergovcancertopicsfactsheetpreventionvitamin-dutm_sourcefeedburnerutm_mediumfeedutm_campaignfeed20ncifactsheets20nci20fact20sheets">&lt;a href="http://www.cancer.gov/cancertopics/factsheet/prevention/vitamin-D?utm_source=feedburner&amp;amp;utm_medium=feed&amp;amp;utm_campaign=Feed:%20ncifactsheets%20(NCI%20Fact%20Sheets)">Vitamin D and Cancer Prevention&lt;/a>&lt;/h2>
&lt;h4 id="key-points">Key Points&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>Vitamin D helps the body use calcium and phosphorus to make strong bones and teeth. It is obtained primarily through exposure of the skin to sunlight, but it can also be obtained from some foods and dietary supplements.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Many studies in humans, but not all, suggest that higher intakes of vitamin D or higher levels of vitamin D in the blood are associated with a reduced risk of colorectal cancer.&lt;/p></description></item><item><title>Vitamin D proven to treat or prevent many cancers in animals, but only breast cancer in humans so far</title><link>/posts/vitamin-d-proven-to-treat-or-prevent-many-cancers-in-animals-but-only-breast-cancer-in-humans-so-far.html</link><pubDate>Fri, 10 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-proven-to-treat-or-prevent-many-cancers-in-animals-but-only-breast-cancer-in-humans-so-far.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#references">References&lt;/a>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#chen-abstract">Chen Abstract&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h1 id="vitamin-d-and-cancer-the-promise-not-yet-fulfilled">Vitamin D and cancer: the promise not yet fulfilled&lt;/h1>
&lt;p>Endocrine. 2014 Jan 9.&lt;/p>
&lt;p>Bikle DD.&lt;/p>
&lt;p>The negative association of the latitude where people live and the incidence of non cutaneous cancer in that population in North America have been demonstrated in many studies for many types of cancer. Since the intensity of UVB exposure decreases with increasing latitude, and UVB exposure provides the mechanism for vitamin D production in the skin, the hypothesis that increased vitamin D provides protection against the development of cancer has been proposed. This hypothesis has been tested in a substantial number of prospective and case control studies and in a few randomized clinical trials (RTC) assessing whether either vitamin D intake or serum levels of 25 hydroxyvitamin D (25OHD) correlate (inversely) with cancer development. Most of the studies have focused on colorectal, breast, and prostate cancer. The results have been mixed. The most compelling data for a beneficial relationship between vitamin D intake or serum 25OHD levels and cancer have been obtained for colorectal cancer.&lt;/p></description></item><item><title>Cancer and low vitamin D – which causes which</title><link>/posts/cancer-and-low-vitamin-d-which-causes-which.html</link><pubDate>Tue, 07 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/cancer-and-low-vitamin-d-which-causes-which.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#the-inverse-relationship-between-25-hydroxyvitamin-d-and-cáncer-survival-discussion-of-causation">The Inverse Relationship between 25-Hydroxyvitamin D and Cáncer Survival: Discussion of Causation&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#review-of-survival-studies">Review of Survival Studies&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#figure-1-hazard-ratios">Figure 1. Hazard Ratios&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#breast-cancer">Breast Cancer&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#colorectal-cancer">Colorectal Cancer&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#prostate-cancer">Prostate Cancer&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#lung-cancer">Lung Cancer&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#hematologic-cancers">Hematologic Cancers&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#other-cancers">Other Cancers&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#discussion">Discussion&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#31temporality">3.1Temporality&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#32-strength-and-exposure-response-relationship">3.2 Strength and Exposure-Response Relationship&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#biological-plausibility">Biological Plausibility&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#consistency">Consistency&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#reversibility">Reversibility&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#coherence">Coherence&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#4-conclusions">4. Conclusions&lt;/a>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#references-and-tables-are-in-pdf-at-bottom-of-this-page">References and tables are in PDF at bottom of this page&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h2 id="the-inverse-relationship-between-25-hydroxyvitamin-d-and-cáncer-survival-discussion-of-causation">The Inverse Relationship between 25-Hydroxyvitamin D and Cáncer Survival: Discussion of Causation&lt;/h2>
&lt;p>Cancers 2013, 5, 1439-1455; doi:10.3390/cancers5041439&lt;/p></description></item><item><title>Cancer incidence in 87 countries is related to food, smoking, alcohol, GDP, and UVB</title><link>/posts/cancer-incidence-in-87-countries-is-related-to-food-smoking-alcohol-gdp-and-uvb.html</link><pubDate>Fri, 27 Dec 2013 00:00:00 +0000</pubDate><guid>/posts/cancer-incidence-in-87-countries-is-related-to-food-smoking-alcohol-gdp-and-uvb.html</guid><description>&lt;div>
&lt;p>
&lt;p>Nutrients 2014, 6, 163-189; doi:10.3390/nu6010163&lt;/p>&lt;/p>
&lt;p>
&lt;p>&lt;strong>&lt;span style="font-size:14px;">A Multicountry Ecological Study of Cáncer Incidence Rates in 2008 with Respect to Various Risk-Modifying Factors&lt;/span>&lt;/strong>&lt;/p>&lt;/p>
&lt;p>
&lt;p>William B. Grant&lt;/p>&lt;/p>
&lt;p align="left">
&lt;p>Sunlight, Nutrition, and Health Research Center, P.O. Box 641603, San Francisco, CA 94164-1603, USA; E-Mail: &lt;a href="mailto:wbgrant@infionline.net">&lt;a href="mailto:wbgrant@infionline.net">wbgrant@infionline.net&lt;/a>&lt;/a>; Tel.: +1-415-409-1980&lt;/p>&lt;/p>
&lt;p>
&lt;p>Received: 6 November 2013; in revised form: 12 December 2013 /Accepted: 14 December 2013 / Published: 27 December 2013&lt;/p>&lt;/p>
&lt;p style="margin-left:.4in;">
&lt;p>Abstract: Observational and ecological studies are generally used to determine the presence of effect of cancer risk-modifying factors. Researchers generally agree that environmental factors such as smoking, alcohol consumption, poor diet, lack of physical activity, and low serum 25-hdyroxyvitamin D levels are important cancer risk factors. This ecological study used age-adjusted incidence rates for 21 cancers for 157 countries (87 with high-quality data) in 2008 with respect to dietary supply and other factors, including per capita gross domestic product, life expectancy, lung cancer incidence rate (an index for smoking), and latitude (an index for solar ultraviolet-B doses). The factors found to correlate strongly with multiple types of cancer were lung cancer (direct correlation with 12 types of cancer), energy derived from animal products (direct correlation with 12 types of cancer, inverse with two), latitude (direct correlation with six types, inverse correlation with three), and per capita gross national product (five types). Life expectancy and sweeteners directly correlated with three cancers, animal fat with two, and alcohol with one. Consumption of animal products correlated with cancer incidence with a lag time of 15-25 years. Types of cancer which correlated strongly with animal product consumption, tended to correlate weakly with latitude; this occurred for 11 cancers for the entire set of countries. Regression results were somewhat different for the 87 high-quality country data set and the 157-country set. Single-country ecological studies have inversely correlated nearly all of these cancers with solar ultraviolet-B doses. These results can provide guidance for prevention of cancer.&lt;/p></description></item><item><title>Skin cancer increases other cancers (low-vitamin D)</title><link>/posts/skin-cancer-increases-other-cancers-low-vitamin-d.html</link><pubDate>Wed, 18 Dec 2013 00:00:00 +0000</pubDate><guid>/posts/skin-cancer-increases-other-cancers-low-vitamin-d.html</guid><description>&lt;h2 id="skin-cancer-may-increase-subsequent-primary-malignancy-riskhttpdrkenboakewordpresscomtagvitamin-d20-dr-boake">&lt;a href="http://drkenboake.wordpress.com/tag/vitamin-d/%20">Skin cancer may increase subsequent primary malignancy risk&lt;/a> Dr. Boake&lt;/h2>
&lt;p>Research suggests that people with non-melanoma skin cancer (NMSC) are at moderately increased risk for developing other primary malignancies in the future, particularly breast and lung cancer and melanoma.&lt;/p>
&lt;p>Vitamin D was not mentioned&lt;/p></description></item><item><title>Cancer Survival is poor if vitamin D is less than 20ng (every study showed benefit)– review</title><link>/posts/cancer-survival-is-poor-if-vitamin-d-is-less-than-20ng-every-study-showed-benefit-review.html</link><pubDate>Wed, 06 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/cancer-survival-is-poor-if-vitamin-d-is-less-than-20ng-every-study-showed-benefit-review.html</guid><description>&lt;h3 id="the-inverse-relationship-between-25-hydroxyvitamin-d-and-cancer-survival-discussion-of-causation">The Inverse Relationship between 25-Hydroxyvitamin D and Cancer Survival: Discussion of Causation&lt;/h3>
&lt;p>Cancers 2013, 5(4), 1439-1455; doi:10.3390/cancers5041439&lt;/p>
&lt;p>Trude E. Robsahm 1 &lt;a href="mailto:trude.eid.robsahm@kreftregisteret.no">trude.eid.robsahm@kreftregisteret.no&lt;/a> , Gary G. Schwartz 2 and Steinar Tretli 1&lt;/p>
&lt;p>1 The Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo 0304, Norway 2 Departments of Cancer Biology, Urology, and Epidemiology and Prevention, Wake Forest University Baptist Medical Center, Winston-Salem, NC 27157, USA&lt;/p>
&lt;p>Received: 22 September 2013; in revised form: 22 October 2013 / Accepted: 24 October 2013 / Published: 5 November 2013&lt;/p></description></item><item><title>People more likely to freckle are more likely to get prostate cancer (low vitamin D)</title><link>/posts/people-more-likely-to-freckle-are-more-likely-to-get-prostate-cancer-low-vitamin-d.html</link><pubDate>Fri, 01 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/people-more-likely-to-freckle-are-more-likely-to-get-prostate-cancer-low-vitamin-d.html</guid><description>&lt;h4 id="using-genetic-proxies-for-lifecourse-sun-exposure-to-assess-the-causal-relationship-of-sun-exposure-with-circulating-vitamin-d-and-prostate-cancer-risk">Using genetic proxies for lifecourse sun exposure to assess the causal relationship of sun exposure with circulating vitamin d and prostate cancer risk.&lt;/h4>
&lt;p>Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):597-606. &lt;a href="https://doi.org/10.1158/1055-9965.EPI-12-1248.">doi: 10.1158/1055-9965.EPI-12-1248.&lt;/a> Epub 2013 Feb 25.&lt;/p>
&lt;p>Bonilla C, Gilbert R, Kemp JP, Timpson NJ, Evans DM, Donovan JL, Hamdy FC, Neal DE, Fraser WD, Davey SG, Lewis SJ, Lathrop M, Martin RM.&lt;/p>
&lt;p>School of Social and Community Medicine, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, United Kingdom.&lt;/p></description></item><item><title>National Cancer Institute noticing Vitamin D</title><link>/posts/national-cancer-institute-noticing-vitamin-d.html</link><pubDate>Tue, 29 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/national-cancer-institute-noticing-vitamin-d.html</guid><description>&lt;h2 id="vitamin-d-and-cancer-preventionhttpwwwcancergovcancertopicsfactsheetpreventionvitamin-d-at-cancergov">&lt;a href="http://www.cancer.gov/cancertopics/factsheet/prevention/vitamin-D">Vitamin D and Cancer Prevention&lt;/a> at Cancer.gov&lt;/h2>
&lt;h3 id="unfortunately-they">Unfortunately they&lt;/h3>
&lt;ul>
&lt;li>
&lt;p>hide the information deep in their website&lt;/p>
&lt;/li>
&lt;li>
&lt;p>are still considering Vitamin D2&lt;/p>
&lt;/li>
&lt;li>
&lt;p>are waiting for clinical trials to finish in 2017&lt;/p>
&lt;/li>
&lt;/ul>
&lt;h2 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h2>
&lt;ul>
&lt;li>&lt;a href="/posts/overview-cancer-and-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Overview Cancer and vitamin D">Overview Cancer and vitamin D&lt;/a> both PREVENT and TREAT: has the following chart&lt;/li>
&lt;/ul>
&lt;img src="/attachments/d3.mock.jpg" alt="image"></description></item><item><title>Appears that IBD lowers vitamin D, which increases risk of cancer by 80 percent</title><link>/posts/appears-that-ibd-lowers-vitamin-d-which-increases-risk-of-cancer-by-80-percent.html</link><pubDate>Mon, 28 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/appears-that-ibd-lowers-vitamin-d-which-increases-risk-of-cancer-by-80-percent.html</guid><description>&lt;h4 id="association-between-reduced-plasma-25-hydroxy-vitamin-d-and-increased-risk-of-cancer-in-patients-with-inflammatory-bowel-diseases">Association Between Reduced Plasma 25-hydroxy Vitamin D and Increased Risk of Cancer in Patients with Inflammatory Bowel Diseases&lt;/h4>
&lt;p>Clinical Gastroenterology and Hepatology&lt;/p>
&lt;p>Ashwin N. Ananthakrishnan1, 2, Corresponding author contact information, E-mail the corresponding author,&lt;/p>
&lt;p>Su-Chun Cheng3, Tianxi Cai3, Andrew Cagan4, Vivian S. Gainer4, Peter Szolovits6, Stanley Y. Shaw2, 8, Susanne Churchill9, Elizabeth W. Karlson2, 10, Shawn N. Murphy2, 4, 11, Isaac Kohane2, 5, 9, Katherine P. Liao2, 10&lt;/p>
&lt;p>1 Division of Gastroenterology, Massachusetts General Hospital, Boston, MA&lt;/p></description></item><item><title>4 uses of tanning beds per year did not reduce rate of internal cancers</title><link>/posts/4-uses-of-tanning-beds-per-year-did-not-reduce-rate-of-internal-cancers.html</link><pubDate>Wed, 16 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/4-uses-of-tanning-beds-per-year-did-not-reduce-rate-of-internal-cancers.html</guid><description>&lt;h3 id="tanning-bed-use-is-not-associated-with-internal-cancer-risk-evidence-from-a-large-cohort-study">Tanning bed use is not associated with internal cancer risk: Evidence from a large cohort study&lt;/h3>
&lt;p>Cancer Epidemiology, Biomarkers &amp;amp; Prevention&lt;/p>
&lt;p>Mingfeng Zhang1,&lt;/p>
&lt;p>Fengju Song2,&lt;/p>
&lt;p>David J. Hunter3,&lt;/p>
&lt;p>Abrar A. Qureshi4, and&lt;/p>
&lt;p>Jiali Han4,*&lt;/p>
&lt;p>1Dermatology, Brigham and Women&amp;rsquo;s Hospital&lt;/p>
&lt;p>2Dermatology, Brigham and Women&amp;rsquo;s Hospital and Harvard Medical School&lt;/p>
&lt;p>3Program in Molecular and Genetic Epidemiology, Harvard School of Public Health&lt;/p>
&lt;p>4Medicine, Channing Laboratory, Brigham and Women&amp;rsquo;s Hospital and Harvard Medical School&lt;/p></description></item><item><title>Vitamin d - pivotal nutraceutical in the regulation of cancer metastasis and angiogenesis. – 2013</title><link>/posts/vitamin-d-pivotal-nutraceutical-in-the-regulation-of-cancer-metastasis-and-angiogenesis-2013.html</link><pubDate>Mon, 07 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-pivotal-nutraceutical-in-the-regulation-of-cancer-metastasis-and-angiogenesis-2013.html</guid><description>&lt;p>Curr Med Chem. 2013;20(33):4109-20.&lt;/p>
&lt;p>Xu J, Li W, Ma J, Liu J, Sha H, Zhou S, Wang F, Ma Q.&lt;/p>
&lt;p>Department of Hepatobiliary Surgery, The First Affiliated Hospital of Medical College, Xi&amp;rsquo;an Jiaotong University, 277 West Yanta Road, Xi&amp;rsquo;an 710061, China. &lt;a href="mailto:qyma56@mail.xjtu.edu.cn">qyma56@mail.xjtu.edu.cn&lt;/a>.&lt;/p>
&lt;p>Various epidemiological studies have demonstrated that vitamin D may play important roles in the pathogenesis and progression of cancer.&lt;/p>
&lt;p>Vitamin D is one of the most pivotal nutraceuticals whose active metabolite, calcitriol (1,25-dihydroxyvitamin D3), possesses anti-proliferative, pro-apoptotic, and pro-differentiating capabilities.&lt;/p></description></item><item><title>Molecular Link between Vitamin D and Cancer Prevention</title><link>/posts/molecular-link-between-vitamin-d-and-cancer-prevention.html</link><pubDate>Wed, 02 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/molecular-link-between-vitamin-d-and-cancer-prevention.html</guid><description>&lt;p>Nutrients 2013, 5(10), 3993-4021; doi:10.3390/nu5103993&lt;/p>
&lt;p>Meis Moukayed 1email and William B. Grant 2,* email&lt;/p>
&lt;p>1 School of Arts and Sciences, American University in Dubai, P. O. Box 28282, Dubai, UAE&lt;/p>
&lt;p>2 Sunlight, Nutrition, and Health Research Center, San Francisco, CA 94164-1603, USA&lt;/p>
&lt;ul>
&lt;li>Author to whom correspondence should be addressed.&lt;/li>
&lt;/ul>
&lt;p>Received: 7 August 2013; in revised form: 11 September 2013 / Accepted: 18 September 2013 / Published: 30 September 2013&lt;/p>
&lt;p>(This article belongs to the Special Issue Vitamin D and Human Health)&lt;/p></description></item><item><title>Review of cancer and supplements includes vitamin D</title><link>/posts/review-of-cancer-and-supplements-includes-vitamin-d.html</link><pubDate>Wed, 25 Sep 2013 00:00:00 +0000</pubDate><guid>/posts/review-of-cancer-and-supplements-includes-vitamin-d.html</guid><description>&lt;h2 id="integrating-dietary-supplements-into-cancer-care">Integrating Dietary Supplements Into Cancer Care&lt;/h2>
&lt;p>Integr Cancer Ther September 2013 vol. 12 no. 5 369-384&lt;/p>
&lt;p>Moshe Frenkel, MD1,2,*&lt;/p>
&lt;p>Donald I. Abrams, MD3&lt;/p>
&lt;p>Elena J. Ladas, MS, RD4&lt;/p>
&lt;p>Gary Deng, MD5&lt;/p>
&lt;p>Mary Hardy, MD6&lt;/p>
&lt;p>Jillian L. Capodice, LAC, MS7&lt;/p>
&lt;p>Mary F. Winegardner, PA-C, MPAS8&lt;/p>
&lt;p>J. K. Gubili, MS5&lt;/p>
&lt;p>K. Simon Yeung, PharmD, MBA, LAc5&lt;/p>
&lt;p>Heidi Kussmann, ND, FABNO9&lt;/p>
&lt;p>Keith I. Block, MD10&lt;/p>
&lt;p>1University of Texas, Houston, TX, USA&lt;/p>
&lt;p>2Oncology Institute, Meir Medical Center, Kfar Saba, Israel&lt;/p></description></item><item><title>Death of women from cancer 24% less likely if 20 ng more vitamin D – meta-analysis</title><link>/posts/death-of-women-from-cancer-24-percent-less-likely-if-20-ng-more-vitamin-d-meta-analysis.html</link><pubDate>Tue, 17 Sep 2013 00:00:00 +0000</pubDate><guid>/posts/death-of-women-from-cancer-24-percent-less-likely-if-20-ng-more-vitamin-d-meta-analysis.html</guid><description>&lt;h4 id="circulating-25-hydroxyvitamin-d-serum-concentration-and-total-cancer-incidence-and-mortality-a-systematic-review-and-meta-analysis">Circulating 25-hydroxyvitamin D serum concentration and total cancer incidence and mortality: a systematic review and meta-analysis.&lt;/h4>
&lt;p>Prev Med. 2013 Sep 10. pii: S0091-7435(13)00318-6. &lt;a href="https://doi.org/10.1016/j.ypmed.2013.08.026.">doi: 10.1016/j.ypmed.2013.08.026.&lt;/a>&lt;/p>
&lt;p>Yin L, Mena JM, Chen T, Schöttker B, Arndt V, Brenner H.&lt;/p>
&lt;p>Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.&lt;/p>
&lt;p>OBJECTIVE: To conduct a systematic review and meta-analysis of longitudinal studies on the association of 25(OH)D with total cancer incidence and mortality.&lt;/p></description></item><item><title>Probably need more than 1000 IU of vitamin D to prevent cancer – meta-analysis</title><link>/posts/probably-need-more-than-1000-iu-of-vitamin-d-to-prevent-cancer-meta-analysis.html</link><pubDate>Sat, 17 Aug 2013 00:00:00 +0000</pubDate><guid>/posts/probably-need-more-than-1000-iu-of-vitamin-d-to-prevent-cancer-meta-analysis.html</guid><description>&lt;h2 id="clinical-outcomes-of-vitamin-d-deficiency-and-supplementation-in-cancer-patients">Clinical outcomes of vitamin D deficiency and supplementation in cancer patients&lt;/h2>
&lt;p>Nutrition Reviews Vol. 71 Issue 8 DOI: 10.1111/nure.12047&lt;/p>
&lt;p>Laisa Teleni1,2,&lt;/p>
&lt;p>Jacqueline Baker3,&lt;/p>
&lt;p>Bogda Koczwara4,&lt;/p>
&lt;p>Michael G. Kimlin5,&lt;/p>
&lt;p>Euan Walpole6,&lt;/p>
&lt;p>Kathy Tsai3,&lt;/p>
&lt;p>Elizabeth A Isenring3,7,*&lt;/p>
&lt;p>1 School of Public Health and Social Work, Queensland University of Technology, Brisbane, Queensland, Australia&lt;/p>
&lt;p>2 Department of Nutrition and Dietetics, Princess Alexandra Hospital, Brisbane, Queensland, Australia&lt;/p>
&lt;p>3 School of Human Movement Studies, University of Queensland, Brisbane, Queensland, Australia&lt;/p></description></item><item><title>Mayo clinic starting Cancer RCT using grossly inadequate 2,000 IU of vitamin D</title><link>/posts/mayo-clinic-starting-cancer-rct-using-grossly-inadequate-2000-iu-of-vitamin-d.html</link><pubDate>Tue, 06 Aug 2013 00:00:00 +0000</pubDate><guid>/posts/mayo-clinic-starting-cancer-rct-using-grossly-inadequate-2000-iu-of-vitamin-d.html</guid><description>&lt;h2 id="vitamin-d-in-the-cancer-patient">Vitamin D in the cancer patient.&lt;/h2>
&lt;p>Curr Opin Support Palliat Care. 2013 Sep;7(3):272-7. &lt;a href="https://doi.org/10.1097/SPC.0b013e3283640f74.">doi: 10.1097/SPC.0b013e3283640f74.&lt;/a>&lt;/p>
&lt;p>Kennel KA, Drake MT.&lt;/p>
&lt;p>Division of Endocrinology, Department of Medicine, Endocrine Research Unit, College of Medicine, Mayo Clinic, Rochester, Minnesota, USA.&lt;/p>
&lt;p>PURPOSE OF REVIEW: To briefly review recent work within the vitamin D and cancer field, whereas also providing context relating how these findings may impact clinical care and future research efforts.&lt;/p>
&lt;p>RECENT FINDINGS: Vitamin D has now been convincingly shown both in vitro and in preclinical animal models to alter the differentiation, proliferation, and apoptosis of cancer cells. Whether vitamin D prevents cancer in humans or limits cancer progression, however, remain open questions. Epidemiologic and observational data relating circulating 25(OH)D levels and cancer risk suggest an inverse relationship for most cancers including breast, colorectal, leukemia and lymphoma, and prostate, although for each malignancy there also exist studies that have failed to demonstrate such an inverse relationship. Likewise, a more recent report failed to confirm a previously reported association of increased pancreatic cancer risk in patients with higher 25(OH)D levels. &lt;strong>A large prospective study in which patients aged at least 50 years receive 2000 IU vitamin D3 daily for 5 years, with cancer as a primary endpoint, has recently been launched.&lt;/strong>&lt;/p></description></item><item><title>Children with Cancer were 3X more likely to be vitamin D deficient</title><link>/posts/children-with-cancer-were-3x-more-likely-to-be-vitamin-d-deficient.html</link><pubDate>Fri, 05 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/children-with-cancer-were-3x-more-likely-to-be-vitamin-d-deficient.html</guid><description>&lt;h4 id="vitamin-d-deficiency-in-children-with-cancer">Vitamin D Deficiency in Children With Cancer.&lt;/h4>
&lt;p>J Pediatr Hematol Oncol. 2013 Jul 3.&lt;/p>
&lt;p>Helou M, Ning Y, Yang S, Irvine P, Bachmann LM, Godder K, Massey G.&lt;/p>
&lt;p>Division of Pediatric Hematology/Oncology, Children&amp;rsquo;s Hospital of Richmond, Medical College of Virginia †Department of Epidemiology and Community Health, Virginia Commonwealth University ‡Medical College of Virginia §Virginia Commonwealth University Health System, Richmond, VA.&lt;/p>
&lt;p>A limited number of small studies have examined the vitamin D status of pediatric oncology patients, and the results indicate an increased prevalence of hypovitaminosis. We conducted a cross-sectional study with the primary aim of describing the vitamin D status of our pediatric cancer patients and any associations with demographic characteristics. Our secondary aim was to compare this prevalence to that of a healthy population. We collected data on children seen in our clinic and determined the overall prevalence of hypovitaminosis. &lt;strong>We then compared this prevalence to that of healthy populations described in the literature&lt;/strong> .&lt;/p></description></item><item><title>Vitamin D protects against many types of health problems – review</title><link>/posts/vitamin-d-protects-against-many-types-of-health-problems-review.html</link><pubDate>Sat, 25 May 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-protects-against-many-types-of-health-problems-review.html</guid><description>&lt;h4 id="vitamin-d-effects-on-musculoskeletal-health-immunity-autoimmunity-cardiovascular-disease-cancer-fertility-pregnancy-dementia-and-mortality-a-review-of-recent-evidence">Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-A review of recent evidence.&lt;/h4>
&lt;p>Autoimmun Rev. 2013 Mar 28. pii: S1568-9972(13)00040-2. &lt;a href="https://doi.org/10.1016/j.autrev.2013.02.004.">doi: 10.1016/j.autrev.2013.02.004.&lt;/a>&lt;/p>
&lt;p>Pawel Pludowski a &lt;a href="mailto:p.pludowski@czd.pl">p.pludowski@czd.pl&lt;/a>&lt;/p>
&lt;p>Michael F. Holick b,&lt;/p>
&lt;p>Stefan Pilzc, d,&lt;/p>
&lt;p>Carol L. Wagner e,&lt;/p>
&lt;p>Bruce W. Hollis e,&lt;/p>
&lt;p>William B. Grant f,&lt;/p>
&lt;p>Yehuda Shoenfeld g,&lt;/p>
&lt;p>Elisabeth Lerchbaum c,&lt;/p>
&lt;p>David J. Llewellyn h,&lt;/p>
&lt;p>Katharina Kienreich c,&lt;/p>
&lt;p>Maya Soni h&lt;/p>
&lt;p>a Department of Biochemistry, Radioimmunology and Experimental Medicine, The Children&amp;rsquo;s Memorial Health Institute, Warsaw, Poland&lt;/p></description></item><item><title>Less Solar Radiation was associated with more Cancer - 1941</title><link>/posts/less-solar-radiation-was-associated-with-more-cancer-1941.html</link><pubDate>Sat, 13 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/less-solar-radiation-was-associated-with-more-cancer-1941.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#the-1941-paper-on-solar-radiation-and-cancer-references-a-1912-paper-on-the-same-subject">The 1941 paper on Solar Radiation and Cancer references a 1912 paper on the same subject&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#cancer-vs-percent-of-agriculture-in-the-state">Cancer vs percent of agriculture in the state&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#cancer-and-latitude">Cancer and latitude&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="the-1941-paper-on-solar-radiation-and-cancer-references-a-1912-paper-on-the-same-subject">The 1941 paper on Solar Radiation and Cancer references a 1912 paper on the same subject&lt;/h4>
&lt;p>&lt;strong>The Relation of Solar Radiation to Cancer Mortality in North America&lt;/strong>&lt;/p>
&lt;p>Frank L. Apperly, M.D.&lt;/p>
&lt;p>(From the Department of Pathology, Medical College o [ Virginia, Richmond, Virginia)&lt;/p></description></item><item><title>Some childhood cancer 30% less likely in parts of California with more UVB</title><link>/posts/some-childhood-cancer-30-percent-less-likely-in-parts-of-california-with-more-uvb.html</link><pubDate>Sat, 13 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/some-childhood-cancer-30-percent-less-likely-in-parts-of-california-with-more-uvb.html</guid><description>&lt;h4 id="solar-uv-radiation-and-cancer-in-young-children">Solar UV radiation and cancer in young children&lt;/h4>
&lt;p>Christina A. Lombardi 1, Julia E. Heck 2, Myles Cockburn 3, and Beate Ritz 4,*&lt;/p>
&lt;p>1 Epidemiology, UCLA Fielding School of Public Health&lt;/p>
&lt;p>2 School of Public Health, University of California&lt;/p>
&lt;p>3 Preventive Medicine, University of Southern California&lt;/p>
&lt;p>4 UCLA Fielding School of Public Health&lt;/p>
&lt;p>↵* Corresponding Author: Beate Ritz, UCLA Fielding School of Public Health, United States &lt;a href="mailto:britz@ucla.edu">britz@ucla.edu&lt;/a>&lt;/p>
&lt;p>Background: Studies have shown that higher UV radiation exposure (UVR) may be related to lower risk of some cancers in adults. Recently an ecological study reported lower risks of some cancers among children living in higher UVR cities and countries. In a large population-based case-control study in California we tested the hypothesis that specific childhood cancers may be influenced by UVR.&lt;/p></description></item><item><title>Cancer associations, including problems with too much vitamin D</title><link>/posts/cancer-associations-including-problems-with-too-much-vitamin-d.html</link><pubDate>Fri, 12 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/cancer-associations-including-problems-with-too-much-vitamin-d.html</guid><description>&lt;h3 id="serum-25-hydroxyvitamin-d-and-cancer-risk-in-older-adults-results-from-a-large-german-prospective-cohort-study">Serum 25-Hydroxyvitamin D and Cancer Risk in Older Adults: Results from a Large German Prospective Cohort Study&lt;/h3>
&lt;p>Cancer Epidemiology, Biomarkers &amp;amp; Prevention, March 5, 2013; &lt;a href="https://doi.org/10.1158/1055-9965.EPI-12-1332">doi: 10.1158/1055-9965.EPI-12-1332&lt;/a>&lt;/p>
&lt;p>José M. Ordóñez-Mena 1, Ben Schöttker 1, Ulrike Haug 2, Heiko Müller 1,&lt;/p>
&lt;p>Josef Köhrle 3, Lutz Schomburg 3, Bernd Holleczek 4, and Hermann Brenner 1&lt;/p>
&lt;p>Authors&amp;rsquo; Affiliations: Divisions of 1Clinical Epidemiology and Aging Research and 2Preventive Oncology, German Cancer Research Center, Heidelberg; 3Institut für Experimentelle Endokrinologie, Charité University Medicine Berlin, Berlin; and 4Saarland Cancer Registry, Saarbrücken, Germany&lt;/p></description></item><item><title>Low vitamin D strongly related to death due to tobacco cancer, but not others</title><link>/posts/low-vitamin-d-strongly-related-to-death-due-to-tobacco-cancer-but-not-others.html</link><pubDate>Sat, 16 Mar 2013 00:00:00 +0000</pubDate><guid>/posts/low-vitamin-d-strongly-related-to-death-due-to-tobacco-cancer-but-not-others.html</guid><description>&lt;h3 id="low-plasma-25-hydroxyvitamin-d-and-risk-of-tobacco-related-cancer">Low Plasma 25-Hydroxyvitamin D and Risk of Tobacco-Related Cancer&lt;/h3>
&lt;p>Clinical Chemistry March 2013&lt;/p>
&lt;p>Shoaib Afzal 1, Stig E. Bojesen 1,2,3 and Børge G. Nordestgaard 1,2,3,*&lt;/p>
&lt;p>1 The Department of Clinical Biochemistry, Herlev Hospital,&lt;/p>
&lt;p>2 The Copenhagen City Heart study, Frederiksberg Hospital, Copenhagen University Hospital, Copenhagen, Denmark;&lt;/p>
&lt;p>3 Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.&lt;/p>
&lt;p>↵*Address correspondence to this author at: Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730 Herlev, Denmark. Fax +45-38683311; e-mail &lt;a href="mailto:Boerge.Nordestgaard@regionh.dk">Boerge.Nordestgaard@regionh.dk&lt;/a>.&lt;/p></description></item><item><title>Vitamin D increasingly associated with inflammation such as RA, TB, Lupus, and cancer</title><link>/posts/vitamin-d-increasingly-associated-with-inflammation-such-as-ra-tb-lupus-and-cancer.html</link><pubDate>Mon, 25 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-increasingly-associated-with-inflammation-such-as-ra-tb-lupus-and-cancer.html</guid><description>&lt;h3 id="there-are-two-articles-on-this-page">There are two articles on this page&lt;/h3>
&lt;hr>
&lt;h3 id="an-update-vitamin-d-deficiency-and-risk-for-rheumatic-diseases">An Update: Vitamin D Deficiency and Risk for Rheumatic Diseases&lt;/h3>
&lt;p>Paul Gatenby, Robyn Lucas, Ashwin Swaminathan&lt;/p>
&lt;p>Curr Opin Rheumatol. 2013;25(2):184-191.&lt;/p>
&lt;h4 id="diseases-include">Diseases include&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>Lupus&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Rheumatoid Arthritis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Juvenile Idiopathic Arthritis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Systemic Vasculitis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Psoriatic Arthritis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Scleroderma&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Behcet&amp;rsquo;s Disease&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Spondyloarthropathies&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Connective Tissue Disease&lt;/p>
&lt;/li>
&lt;/ul>
&lt;p>&lt;strong>PDF is attached at the bottom of this page&lt;/strong>&lt;/p>
&lt;hr>
&lt;h3 id="further-emergent-evidence-for-the-vitamin-d-endocrine-system-involvement-in-autoimmune-rheumatic-disease-risk-and-prognosis">Further emergent evidence for the vitamin D endocrine system involvement in autoimmune rheumatic disease risk and prognosis&lt;/h3>
&lt;p>&lt;strong>Annals of Rheumatic Diseases EDITORIAL&lt;/strong> , April 2013 Vol 72 No 4&lt;/p></description></item><item><title>The sun appears better at reducing incidence of some cancers than vitamin D</title><link>/posts/the-sun-appears-better-at-reducing-incidence-of-some-cancers-than-vitamin-d.html</link><pubDate>Mon, 17 Dec 2012 00:00:00 +0000</pubDate><guid>/posts/the-sun-appears-better-at-reducing-incidence-of-some-cancers-than-vitamin-d.html</guid><description>&lt;h4 id="is-prevention-of-cancer-by-sun-exposure-more-than-just-the-effect-of-vitamin-d--a-systematic-review-of-epidemiological-studies">Is prevention of cancer by sun exposure more than just the effect of vitamin D? -A systematic review of epidemiological studies.&lt;/h4>
&lt;p>Eur J Cancer. 2012 Dec 10. pii: S0959-8049(12)00885-4. &lt;a href="https://doi.org/10.1016/j.ejca.2012.11.001.">doi: 10.1016/j.ejca.2012.11.001.&lt;/a>&lt;/p>
&lt;p>van der Rhee H, Coebergh JW, de Vries E.&lt;/p>
&lt;p>Department of Dermatology, Hagaziekenhuis, P.O. Box 40551, Leyweg 275, 2504 LN Den Haag, Zuid-Holland, The Netherlands. Electronic address: &lt;a href="mailto:hvdrhee@casema.nl">hvdrhee@casema.nl&lt;/a>.&lt;/p>
&lt;p>The number of studies reporting on the association between sunlight exposure, vitamin D and cancer risk is steadily increasing.&lt;/p></description></item><item><title>Relevance of Vitamin D in Bone and Muscle Health of Cancer Patients</title><link>/posts/relevance-of-vitamin-d-in-bone-and-muscle-health-of-cancer-patients.html</link><pubDate>Wed, 05 Dec 2012 00:00:00 +0000</pubDate><guid>/posts/relevance-of-vitamin-d-in-bone-and-muscle-health-of-cancer-patients.html</guid><description>&lt;p>Anti-Cancer Agents in Medicinal Chemistry Volume 13 Issue 1 pp.58-64 (7)&lt;/p>
&lt;p>Author: Heike Bischoff-Ferrari&lt;/p>
&lt;p>Cancer patients with advanced disease frequently feel weak and fatigued, and have an increased risk of fracture. At the same time several reports describe the high prevalence of vitamin D deficiency in these patients. This review will summarize the impact of vitamin D deficiency on muscle weakness and fracture risk. While larger clinical trials of vitamin D supplementation are lacking in cancer patients, the evidence from clinical trials among older adults of the general population support a significant benefit of vitamin D on muscle strength, and fall and fracture reduction.&lt;/p></description></item><item><title>Solar UVB reduces Cancer Risk – Grant,</title><link>/posts/solar-uvb-reduces-cancer-risk-grant.html</link><pubDate>Wed, 05 Dec 2012 00:00:00 +0000</pubDate><guid>/posts/solar-uvb-reduces-cancer-risk-grant.html</guid><description>&lt;h4 id="update-on-evidence-that-support-a-role-of-solar-ultraviolet-b-irradiance-in-reducing-cancer-risk">Update on Evidence that Support a Role of Solar Ultraviolet-B Irradiance in Reducing Cancer Risk&lt;/h4>
&lt;p>Anti-Cancer Agents in Medicinal Chemistry Volume 13 Issue 1 pp.140-146 (7)&lt;/p>
&lt;p>Author: William B. Grant&lt;/p>
&lt;hr>
&lt;h3 id="this-paper-was-in-a-jan-2013-issue-of-span-stylecolor090anti-cancer-agents-in-medicinal-chemistryspan">This paper was in a Jan 2013 issue of &lt;span style="color:#090;">Anti-Cancer Agents in Medicinal Chemistry&lt;/span>&lt;/h3>
&lt;h5 id="articles-copied-to-vitamindwiki-include">Articles copied to VitaminDWiki include&lt;/h5>
&lt;html xmlns:v="urn:schemas-microsoft-com:vml"
&lt;p>xmlns:o=&amp;ldquo;urn:schemas-microsoft-com:office:office&amp;rdquo;&lt;/p>
&lt;p>xmlns:w=&amp;ldquo;urn:schemas-microsoft-com:office:word&amp;rdquo;&lt;/p>
&lt;p>xmlns=&amp;ldquo;&lt;a href="http://www.w3.org/TR/REC-html40%22%3E">http://www.w3.org/TR/REC-html40&amp;quot;&amp;gt;&lt;/a>&lt;/p>
&lt;head>
&lt;meta http-equiv=Content-Type content="text/html; charset=windows-1252">
&lt;meta name=ProgId content=Word.Document>
&lt;meta name=Generator content="Microsoft Word 10">
&lt;meta name=Originator content="Microsoft Word 10">
&lt;link rel=File-List href="Jan%202013%20Special%20Issue_files/filelist.xml">
&lt;title>• Solar UVB reduces Cancer Risk – Grant, Jan 2013&lt;/title>
&lt;!--[if gte mso 9]>&lt;xml>

&lt;/xml>&lt;![endif]-->&lt;!--[if gte mso 9]>&lt;xml>
&lt;p>&lt;/xml>&amp;lt;![endif]&amp;ndash;&amp;gt;&lt;/p></description></item><item><title>The Anti-cancer Actions of Vitamin D</title><link>/posts/the-anti-cancer-actions-of-vitamin-d.html</link><pubDate>Wed, 05 Dec 2012 00:00:00 +0000</pubDate><guid>/posts/the-anti-cancer-actions-of-vitamin-d.html</guid><description>&lt;p>Anti-Cancer Agents in Medicinal Chemistry Volume 13 Issue 1 pp.126-139 (14)&lt;/p>
&lt;p>Authors: Kun-Chun Chiang, Tai C. Chen&lt;/p>
&lt;p>Vitamin D3 is biologically inert. To become active, it requires two successive hydroxylation steps catalyzed by two cytochrome P450 enzymes, first to synthesize the pro-hormone 25-hydroxyvitamin D3 &lt;span>[25(OH)D3]&lt;/span> and then the active hormone 1α,25- dihydroxyvitamin D3 &lt;span>[1α,25(OH)2D3]&lt;/span>. 1α,25(OH)2D3 has high affinity for the vitamin D receptor (VDR), a transcription factor and a member of the steroid receptor superfamily. Through VDR, 1α,25(OH)2D3 regulates more than 200 genes in mammals, including those involved in the calcium and phosphorus homeostasis, immune function, reproduction, cardiovascular, central nerve system, inflammation, angiogenesis, and cellular proliferation, differentiation and apoptosis. Due to its versatile roles in maintaining and regulating normal cellular phenotypes and functions, 1α,25(OH)2D3 has been implicated as an anti-cancer agent. In fact, ecological and epidemiologic data have linked vitamin D deficiency with the incidence and mortality of many types of cancer. More importantly, in vitro and in vivo animal model studies have clearly demonstrated the anti-tumor effects of vitamin D. In this review, we describe the anticancer actions of vitamin D, with special emphasis on different pathways underlying the VDR-mediated genomic as well as less-defined non-genomic actions of vitamin D.&lt;/p></description></item><item><title>Vitamin D and Cancer Mortality – review</title><link>/posts/vitamin-d-and-cancer-mortality-review.html</link><pubDate>Wed, 05 Dec 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-cancer-mortality-review.html</guid><description>&lt;h4 id="vitamin-d-and-cancer-mortality-systematic-review-of-prospective-epidemiological-studies">Vitamin D and Cancer Mortality: Systematic Review of Prospective Epidemiological Studies&lt;/h4>
&lt;p>Anti-Cancer Agents in Medicinal Chemistry Volume 13 Issue 1 pp.107-117 (11)&lt;/p>
&lt;p>Stefan Pilz, Katharina Kienreich, Andreas Tomaschitz, Eberhard Ritz, Elisabeth Lerchbaum, Barbara Obermayer-Pietsch, Veronika Matzi, Joerg Lindenmann, Winfried Marz, Sara Gandini, Jacqueline M. Dekker&lt;/p>
&lt;p>Accumulating evidence from experimental and epidemiological studies suggests that vitamin D deficiency might be a causal risk factor for cancer and therewith associated mortality. We performed a systematic review in Medline up to February 2012 to identify prospective studies on 25-hydroxyvitamin D (25&lt;span>[OH]&lt;/span>D) and cancer mortality as well as on 25(OH)D and survival in cancer patients. Our search retrieved 13 studies on cancer-specific mortality and 20 studies on overall mortality in cancer patients. Data on 25(OH)D and cancer mortality were mainly derived from general populations. The results were inconsistent and yielded either no, inverse or positive associations. By contrast, the majority of studies in cancer patients showed that patients with higher 25(OH)D levels had a decreased risk of mortality. This relationship was particularly evident in cohorts of colorectal cancer patients. In contrast, there was no indication for increased mortality risk with higher vitamin D levels in any cancer cohort. In conclusion, the relationship of vitamin D status and cancer specific mortality is still unclear and warrants further studies. Our results provide a strong rationale to perform prospective randomized controlled studies to document a potential effect of vitamin D supplementation on survival in cancer patients.&lt;/p></description></item><item><title>Vitamin D Supplementation and Cancer - Review of RCT</title><link>/posts/vitamin-d-supplementation-and-cancer-review-of-rct.html</link><pubDate>Wed, 05 Dec 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-supplementation-and-cancer-review-of-rct.html</guid><description>&lt;h1 id="vitamin-d-supplementation-and-cancer">Vitamin D Supplementation and Cancer:&lt;/h1>
&lt;h2 id="review-of-randomized-controlled-trials">Review of Randomized Controlled Trials&lt;/h2>
&lt;p>Anti-Cancer Agents in Medicinal Chemistry Volume 13 Issue 1 pp.118-125 (8)&lt;/p>
&lt;p>Authors: Matteo Lazzeroni, Davide Serrano, Stefan Pilz, Sara Gandini&lt;/p>
&lt;p>Data from experimental studies suggest that vitamin D receptor activation exerts anti-cancer effects on virtually all steps of carcinogenesis. Epidemiological data support an inverse association of vitamin D serum levels and vitamin D receptor polymorphisms with cancer incidence and mortality. Based on this promising rationale for use of vitamin D and its analogues in cancer prevention and treatment, several interventional studies have been initiated and partially published. Trials with vitamin D were mainly organized for the prevention of fracture in elderly people, usually in association with calcium supplements. Prevention studies with vitamin D have rarely been done in the context of vitamin D to evaluate a protective effect on cancer. Findings from prospective cohort studies on colorectal cancer risk and on mortality constitute pieces of evidence strong enough to consider that previous randomized controlled trials (RCTs) of vitamin D use and cancer may not have correctly addressed the question, and that new randomized trials should be organized. The reasons are due to several unsolved issues including selection of the effective dose, varying baseline levels of subjects before randomization, compliance with the intervention, contamination of the placebo group (i.e., intake of vitamin D supplements by subjects allocated to the placebo group) and unknown effective lag time between start of the intervention and disease onset. The present review summarizes the existing knowledge on vitamin D RCTs and cancer. In addition we also briefly describe the design of some ongoing trials on vitamin D supplementation and cancer.&lt;/p></description></item><item><title>Vitamin D, Sunlight and Cancer Connection – Holick</title><link>/posts/vitamin-d-sunlight-and-cancer-connection-holick.html</link><pubDate>Wed, 05 Dec 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-sunlight-and-cancer-connection-holick.html</guid><description>&lt;p>Anti-Cancer Agents in Medicinal Chemistry Volume 13 Issue 1 pp.70-82 (13)&lt;/p>
&lt;p>Author: Michael F. Holick&lt;/p>
&lt;p>&lt;strong>PDF with ALL graphics is attached at the bottom of this page&lt;/strong>&lt;/p>
&lt;p>It has been more than 100 years when it was first appreciated that increased sun exposure reduced risk of dying of cancer. The most beneficial effect of sun exposure is the production of vitamin D in the skin. Recent evidence suggests that most cells in the body not only have a vitamin D receptor but also have the capacity to convert 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D. Once formed 1,25-dihydroxyvitamin D can inhibit cellular proliferation, induce cellular maturation, inhibit angiogenesis and ultimately cause apoptosis to prevent malignancy. A multitude of studies have associated improved vitamin D status with decreased risk for developing several deadly cancers including colon, breast, pancreatic and ovarian cancers. Patients with cancer are at high risk for vitamin D deficiency. Sensible sun exposure, vitamin D fortification and vitamin D supplementation should be encouraged to improve the vitamin D status of children and adults not only for bone health but for reducing risk of developing and dying of cancer. The goal is to achieve a blood level of 25-hydroxyvitamin D of 40-60 ng/mL. This can be accomplished by children taking 600-1000 and adults 1500-2000 international units (IU) vitamin D daily from diet and supplements along with sensible sun exposure when the sun is capable of producing vitamin D in the skin.&lt;/p></description></item><item><title>How Vitamin D prevents many cancers (c-MYC)</title><link>/posts/how-vitamin-d-prevents-many-cancers-c-myc.html</link><pubDate>Sun, 25 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/how-vitamin-d-prevents-many-cancers-c-myc.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-receptor-as-a-master-regulator-of-the-c-mycmxd1-network">Vitamin D receptor as a master regulator of the c-MYC/MXD1 network&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-web">See also web&lt;/a>&lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h2 id="vitamin-d-receptor-as-a-master-regulator-of-the-c-mycmxd1-network">Vitamin D receptor as a master regulator of the c-MYC/MXD1 network&lt;/h2>
&lt;p>PNAS November 13, 2012 vol. 109 no. 46 18827-18832&lt;/p>
&lt;p>Reyhaneh Salehi-Tabara, Loan Nguyen-Yamamotoa, Luz E. Tavera-Mendozaa, Thomas Quailb, Vassil Dimitrovb, Beum-Soo Anb,c, Leon Glassb, David Goltzmana,b, and John H. Whitea,b, &lt;a href="mailto:john.white@mcgill.ca">john.white@mcgill.ca&lt;/a>&lt;/p>
&lt;p>A Departments of Medicine and&lt;/p>
&lt;p>B Physiology, McGill University, Montreal, QC, Canada H3G 1Y6; and&lt;/p></description></item><item><title>Big Pharma continues to seek a patentable form of vitamin D for Breast Cancer</title><link>/posts/big-pharma-continues-to-seek-a-patentable-form-of-vitamin-d-for-breast-cancer.html</link><pubDate>Mon, 12 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/big-pharma-continues-to-seek-a-patentable-form-of-vitamin-d-for-breast-cancer.html</guid><description/></item><item><title>A review of the evidence regarding the solar ultraviolet-B-vitamin D-cancer hypothesis</title><link>/posts/a-review-of-the-evidence-regarding-the-solar-ultraviolet-b-vitamin-d-cancer-hypothesis.html</link><pubDate>Tue, 30 Oct 2012 00:00:00 +0000</pubDate><guid>/posts/a-review-of-the-evidence-regarding-the-solar-ultraviolet-b-vitamin-d-cancer-hypothesis.html</guid><description/></item><item><title>Vitamin D still appears to reduce Cancer Mortality – Systematic Review</title><link>/posts/vitamin-d-still-appears-to-reduce-cancer-mortality-systematic-review.html</link><pubDate>Fri, 26 Oct 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-still-appears-to-reduce-cancer-mortality-systematic-review.html</guid><description>&lt;h1 id="vitamin-d-and-cancer-mortality">Vitamin D and Cancer Mortality:&lt;/h1>
&lt;h2 id="systematic-review-of-prospective-epidemiological-studies">Systematic Review of Prospective Epidemiological Studies.&lt;/h2>
&lt;p>Anticancer Agents Med Chem. 2012 Oct 12.&lt;/p>
&lt;p>Pilz S, Kienreich K, Tomaschitz A, Ritz E, Lerchbaum E, Obermayer-Pietsch B, Matzi V, Lindenmann J, März W, Gandini S, Dekker JM.&lt;/p>
&lt;p>Department of Epidemiology and Biostatistics, EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands. &lt;a href="mailto:stefan.pilz@meduni-graz.at">stefan.pilz@meduni-graz.at&lt;/a>.&lt;/p>
&lt;p>Accumulating evidence from experimental and epidemiological studies suggests that vitamin D deficiency might be a causal risk factor for cancer and therewith associated mortality. We performed a systematic review in Medline up to February 2012 to identify prospective studies on 25-hydroxyvitamin D (25&lt;span>[OH]&lt;/span>D) and cancer mortality as well as on 25(OH)D and survival in cancer patients.&lt;/p></description></item><item><title>CYP24A1 gene in cancer cells may actually remove vitamin D from the blood</title><link>/posts/cyp24a1-gene-in-cancer-cells-may-actually-remove-vitamin-d-from-the-blood.html</link><pubDate>Sat, 13 Oct 2012 00:00:00 +0000</pubDate><guid>/posts/cyp24a1-gene-in-cancer-cells-may-actually-remove-vitamin-d-from-the-blood.html</guid><description>&lt;h4 id="24-hydroxylase-in-cancer-impact-on-vitamin-d-based-anticancer-therapeutics">24-Hydroxylase in Cancer: Impact on Vitamin D-based Anticancer Therapeutics.&lt;/h4>
&lt;p>J Steroid Biochem Mol Biol. 2012 Oct 8. pii: S0960-0760(12)00200-2. &lt;a href="https://doi.org/10.1016/j.jsbmb.2012.09.031">doi: 10.1016/j.jsbmb.2012.09.031&lt;/a>&lt;/p>
&lt;p>Luo W, Hershberger PA, Trump DL, Johnson CS.&lt;/p>
&lt;p>Department of Pharmacology and Therapeutics.&lt;/p>
&lt;p>The active vitamin D hormone 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) plays a major role in regulating calcium homeostasis and bone mineralization. 1,25(OH)(2)D(3) also modulates cellular proliferation and differentiation in a variety of cell types. 24-hydroxylase, encoded by the CYP24A1 gene, is the key enzyme which converts 1,25(OH)(2)D(3) to less active calcitroic acid.&lt;/p></description></item><item><title>Vitamin D levels very low for some childhood cancers, then got lower</title><link>/posts/vitamin-d-levels-very-low-for-some-childhood-cancers-then-got-lower.html</link><pubDate>Sat, 29 Sep 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-levels-very-low-for-some-childhood-cancers-then-got-lower.html</guid><description>&lt;h4 id="vitamin-d-levels-differ-by-cancer-diagnosis-and-decline-over-time-in-survivors-of-childhood-cancer">Vitamin D levels differ by cancer diagnosis and decline over time in survivors of childhood cancer†&lt;/h4>
&lt;p>Pediatric Blood &amp;amp; Cancer DOI: 10.1002/pbc.24349&lt;/p>
&lt;p>Galit P. Rosen MD1,2,*, Kristen L. Beebe MS, PA-C1,3, Gabriel Q. Shaibi PhD4,5&lt;/p>
&lt;p>1 Center for Cancer and Blood Disorders, Phoenix Children&amp;rsquo;s Hospital, Phoenix, Arizona&lt;/p>
&lt;p>2 Department of Child Health, UA College of Medicine-Phoenix, Phoenix, Arizona&lt;/p>
&lt;p>3 Division of Hematology/Oncology, Mayo Clinic Arizona, Phoenix, Arizona&lt;/p>
&lt;p>4 Division of Endocrinology and Diabetes, Phoenix Children&amp;rsquo;s Hospital, Phoenix, Arizona&lt;/p></description></item><item><title>More US deaths due to cancer than heart if dark skinned</title><link>/posts/more-us-deaths-due-to-cancer-than-heart-if-dark-skinned.html</link><pubDate>Tue, 18 Sep 2012 00:00:00 +0000</pubDate><guid>/posts/more-us-deaths-due-to-cancer-than-heart-if-dark-skinned.html</guid><description/></item><item><title>Vitamin D and cancer: a view based of all models</title><link>/posts/vitamin-d-and-cancer-a-view-based-of-all-models.html</link><pubDate>Tue, 21 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-cancer-a-view-based-of-all-models.html</guid><description>&lt;h1 id="vitamin-d-and-cancer-integration-of-cellular-biology-molecular-mechanisms-and-animal-models">Vitamin D and cancer: integration of cellular biology, molecular mechanisms and animal models.&lt;/h1>
&lt;p>Welsh J.&lt;/p>
&lt;p>Scand J Clin Lab Invest Suppl. 2012 Apr;243:103-11.&lt;/p>
&lt;p>Cancer Research Center, University at Albany, Rensselaer, NY 12144, USA. &lt;a href="mailto:jwelsh@albany.edu">jwelsh@albany.edu&lt;/a>&lt;/p>
&lt;p>&lt;strong>&lt;span style="color:#090;">Probably presented at the Bermeyer Coonference in Garmishpartenkirchen (Germany) in March 2012&lt;/span>&lt;/strong>&lt;/p>
&lt;p>Epidemiologic data suggest that the incidence and severity of many types of cancer inversely correlates with indices of vitamin D status. The vitamin D receptor (VDR) is highly expressed in epithelial cells at risk for carcinogenesis including those resident in skin, breast, prostate and colon, providing a direct molecular link by which vitamin D status impacts on carcinogenesis. Consistent with this concept, activation of VDR by its ligand 1,25-dihydroxyvitamin D (1,25(OH)(2)D) triggers comprehensive genomic changes in epithelial cells that contribute to maintenance of the differentiated phenotype, resistance to cellular stresses and protection of the genome. Many epithelial cells also express the vitamin D metabolizing enzyme CYP27B1 which enables autocrine generation of 1,25(OH)(2)D from the circulating vitamin D metabolite 25-hydroxyvitamin D (25(OH)D), critically linking overall vitamin D status with cellular anti-tumor actions. Furthermore, pre-clinical studies in animal models have demonstrated that dietary supplementation with vitamin D or chronic treatment with VDR agonists decreases tumor development in skin, colon, prostate and breast. Conversely, deletion of the VDR gene in mice alters the balance between proliferation and apoptosis, increases oxidative DNA damage, and enhances susceptibility to carcinogenesis in these tissues. Because VDR expression is retained in many human tumors, vitamin D status may be an important modulator of cancer progression in persons living with cancer. Collectively, these observations reinforce the need to further define the molecular actions of the VDR and the human requirement for vitamin D in relation to cancer development and progression.&lt;/p></description></item><item><title>Review of Cancer and Vitamin D</title><link>/posts/review-of-cancer-and-vitamin-d.html</link><pubDate>Wed, 01 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/review-of-cancer-and-vitamin-d.html</guid><description>&lt;p>Vitamin D and Cancer&lt;/p>
&lt;p>Frontier Endocrinol (Lausanne). 2012; 3: 58.&lt;/p>
&lt;p>Published online 2012 April 23. Prepublished online 2012 February 20. PMCID: PMC3355893&lt;/p>
&lt;p>Laura Vuolo,1,* Carolina Di Somma,2 Antongiulio Faggiano,1 and Annamaria Colao1&lt;/p>
&lt;p>Vitamin D system is a complex pathway that includes precursors, active metabolites, enzymes, and receptors.&lt;/p>
&lt;p>This complex system actives several molecular pathways and mediates a multitude of functions.&lt;/p>
&lt;p>In addition to the classical role in calcium and bone homeostasis, vitamin D plays “non-calcemic” effects in host defense, inflammation, immunity, and cancer processes as recognized in vitro and in vivo studies.&lt;/p></description></item><item><title>Photodynamic therapy for Cancer might be helped by vitamin D</title><link>/posts/photodynamic-therapy-for-cancer-might-be-helped-by-vitamin-d.html</link><pubDate>Tue, 31 Jul 2012 00:00:00 +0000</pubDate><guid>/posts/photodynamic-therapy-for-cancer-might-be-helped-by-vitamin-d.html</guid><description>&lt;h3 id="biomodulatory-approaches-to-photodynamic-therapy-for-solid-tumors">Biomodulatory Approaches to Photodynamic Therapy for Solid Tumors.&lt;/h3>
&lt;p>Cancer Lett. 2012 Jul 25.&lt;/p>
&lt;p>Anand S, Ortel BJ, Pereira SP, Hasan T, Maytin EV.&lt;/p>
&lt;p>Departments of Dermatology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA; Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.&lt;/p>
&lt;p>Photodynamic Therapy (PDT) uses a photosensitizing drug in combination with visible light to kill cancer cells. PDT has an advantage over surgery or ionizing radiation because PDT can eliminate tumors without causing fibrosis or scarring. Disadvantages include the dual need for drug and light, and a generally lower efficacy for PDT versus surgery. This minireview describes basic principles of PDT, photosensitizers available, and aspects of tumor biology that may provide further opportunities for treatment optimization. An emerging biomodulatory approach, using methotrexate or Vitamin D in combination with aminolevulinate-based PDT, is described. Finally, current clinical uses of PDT for solid malignancies are reviewed.&lt;/p></description></item><item><title>Vitamin D in Cancer Patients: Above All, Do No Harm – 2009</title><link>/posts/vitamin-d-in-cancer-patients-above-all-do-no-harm-2009.html</link><pubDate>Wed, 25 Jul 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-in-cancer-patients-above-all-do-no-harm-2009.html</guid><description>&lt;p>Journal of Clinical Oncology May 1, 2009 vol. 27 no. 13 2117-2119&lt;/p>
&lt;p>Pamela J. Goodwin&lt;/p>
&lt;p>Samuel Lunenfeld Research Institute, Mount Sinai Hospital and Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada&lt;/p>
&lt;p>In this issue of Journal of Clinical Oncology, Crew et al 1 report results of an examination of vitamin D in 103 premenopausal breast cancer patients who participated in a 1-year trial of zoledronate compared with placebo, in which all women received daily vitamin D (400 IU) and calcium (1,000 mg). Seventy-four percent of women were vitamin D deficient at study entry shortly after diagnosis; deficiency was more common in black and Hispanic women than in white women. After 1 year, less than 15% of the white women (but no Hispanic or black women) who had been vitamin D deficient at baseline achieved sufficient levels in their blood. The authors conclude, “…our study suggests that a dose of 400 IU daily is inadequate in breast cancer patients even to maintain skeletal health, and is probably too low for meaningful anticancer effects.” They go on to comment that controversy exists as to the upper safe daily limit of vitamin D supplementation and suggest “…it may be prudent to follow serum levels of 25-OHD &lt;span>[25-hydroxyvitamin D]&lt;/span>…” This carefully conducted study echoes results recently reported by Neuhouser et al 2 (that approximately three fourths of patients with breast cancer from Los Angeles had inadequate blood levels of vitamin D) and by our group3 (that the same proportion of patients with breast cancer in Toronto had inadequate levels).&lt;/p></description></item></channel></rss>